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THESIS SUMMARY
The protein products of the myc farrily of proto-oncogenes regulate a wide variety of
cellular processes, such as proliferation, apoptosis and cell growth. The importance of this
family of genes is highlighted by the observation that their absence in mouse development
results in significant defects and death during early embryogenesis.
Investigation into the events of early embryogenesis can be modelled in the laboratory via
the use of mouse embryonic stem (mES) cells, which are derived from the inner cell mass
(ICM) of the mouse embryo and are equivalent to 4.5 days post coitum (dpc). An
important characteristic of ES cells is that they are pluripotent, meaning that they have the
potential to form every embryonic cell type. Maintenance of a pluripotent state, in culture
is achieved by the exposure to the cytokine, Leukemia Inhibitory Factor (LIF).
Differentiation of ES cells can achieved in cell culture in various rways, one of which leads
to the formation of structures called embryoid bodies. These can be used as an in vitro
model for embryonic differentiation of cells of the pluripotent ICM to the three primary
germ layers, Ectoderm, Endoderm and Mesoderm. In the embryo and embryoid bodies it
has be demonstrated that the differentiation of pluripotent cells into the germ layers there is
a deceleration in the cell cycle times and adoption of a more tightly regulated cell cycle.
It was the focus of this research to investigate the role of c-Myc protein in the
differentiation of pluripotent embryonic stem cells into the three primary germ layers. To
analyse the association of c-Myc protein with changes in cell cycle kinetics Western Blot
Analysis was utilised. In this experiment, two distinct protein species were detected in
early time points but were down-regulated as differentiation proceeded. Based on the
V1
estimated size of the proteins detected it was proposed that one of the bands was fuIl-
length c-Myc and the other was the shorter, differentially translated c-Myc subtype, c-
MycS. Specific antibodies generated in the course of this research demonstrated that the
shorter band detected in the Westem Analysis was c-MycS, which illustrated that
translation of the c-Myc protein is differentially regulated during differentiation of ES
cells.
This thesis also describes the impact of c-Myc over-expression on differentiation and the
maintenance of pluripotency. This effect was analysed during embryoid body
differentiation experiments utilising Northem blot detection of RNA markers, which
showed delayed differentiation kinetics. LIF titration assays demonstrated that c-Myc over-
expression decreased dependence on LIF for ES cells to maintain pluripotency.
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1. 1 Mammølian Embryonic D evelopm ent
Embryogenesis begins with fertilisation of the egg. This single cell is the progenitor of
most extra-embryonic membranes and all the cell lineages that comprise the embryo and
the adult. The initial stages of mammalian development entail an increase in cell number
without alteration in cellular differentiation potential (reviewed in Hogan et a1.,1994). The
first differentiation event occurs at approximately 2.5 days post coitum (dpc), at the 16 cell
morula stage, where the outer cells give rise to the extra-embryonic trophectoderm lineage
while the inner cells form the first pluripotent cell population of the embryo, the inner cell
mass (ICM) (Gardner, 1983). Pluripotence is defined as retaining the potential to
contribute progeny to all embryonic lineages. Between 2.5 and 3.5 dpc, fluid accumulates
within the embryo that extrudes the ICM to one side of the embryo, forming the blastocelic
cavity ('Watson and Kidder, 1988). By 4.5 dpc the outer ICM cells, adjacent to the cavity,
have differentiated into an additional extra-embryonic lineage, termed primitive endoderm,
while the remainder of the ICM forms the pluripotent epiblast. At 4.5 dpc the embryo
implants into the uterus (reviewed in Hogan et al., 1994). Following implantation, the
pluripotent cells of the epiblast undergo a period of rapid proliferation between 5.5 and 6.5
dpc, where cell cycle times drop as low as 5-7 hours (Snow, l9l7; Poelmann, 1980;
Lawson et al., 199I). Furthermore, during this stage of development, the pluripotent
epiblast cells differentiate into aî additional pluripotent lineage, termed primitive
ectoderm. Primitive ectoderm is a pseudo-stratified epithelial monolayer of cells
surrounding a central pro-amniotic cavity. The pro-amniotic cavity forms around 5.0 dpc
by thc induction of programmed cell death in the central pluripotent cells through the
1
action of a diffusible 'death' signal, eminating from a lineage of the primitive endoderm,
the visceral endoderm, that lies adjacent to the pluripotent cell mass. The outer pluripotent
cells survive this apoptotic signal through interaction with arì extra-cellular matrix
associated survival signal in the basement membrane separating visceral endoderm and
primitive ectoderm (Coucouvanis and Martin, 1995).
The primitive ectoderm is the pluripotent cell substrate for the process of gastrulation at
approximately 6.5 dpc. It is at this stage of development when cells first lose pluripotency
and form the three primary germ layers, ectoderm, endoderm and mesoderm (Ginsberg et
aL.,1990). The onset of gastrulation is defined by the appearance of the primitive streak on
the posterior most end of the embryo, where pluripotent cells differentiate into definitive
mesoderm. The emerging embryonic mesoderm migrates between the primitive ectoderm
and the visceral endoderm from the most posterior embryonic region to the distal tip of the
embryo. In the period of 4.5-6 dpc cell cycle times are thought to be as low as 10 hours.
Following mesoderm formation the cell cycle transition times have slowed to predicted
rates of 22.2 hours at day 7 (Snow, 1977). This indicates that as the pluripotent cells of the
embryo differentiate into non-pluripotent cells, there is major remodelling of the cell cycle.
1.2 The Myc Fømily
Mammalian cells respond to extracellular stimuli via the activation of immediate early (IE)
genes, which produce proteins that elicit the appropriate cellular responses. One of such
group of IE genes are the myc famlly (Winkles, 1998). The protein products of Lhe myc
family of proto-oncogenes are nuclear localised and involved in a wide variety of cellular
functions such as cell proliferation, growth and apoptosis (Ryan and Birnie, 1996). They
have been extensively investigated as a targel for chromosomal translocations,
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reaffangements, mutations and amplifications, which enhance its activity in wide variety of
cancers (Lutz et al., 2002). In fact, myc was discovered through its homology to the
transforming gene, v-myc, of the avian myelocytomatosis virus, MC29 (Yennsffom et al,
1 e82).
There are several members of the myc famlly, the most characterised of which are c-, L-
andN-myc. The transactivation domain, located at the N-terminus (amino acids 1-143),
contains two 'myc boxes', MBI and MBII, which are areas of strong homology between
the family members (Kato et al., 1990; Atchley and Fitch, 1995). The C-terminus of the
protein contains a basic helix-loop-helix, leucine zipper (b-HLH-LZ) domain, which
enables dimerisation to partner proteins and binding to promoters of genes containing a
consensus CACGTG sequence, termed the E-box (reviewed in Ryan and Birnie, 1996;
Grandori et aL.,2000). Myc proteins also contain a centrally positioned nuclear localisation
signal (NLS) (Ryan and Birnie, 1996). A schematic diagram of the structure of Myc is
shown in Figure 1.1. Myc has been shown to have a very short half-life, approximately 30
minutes, and is ubiquitinated and degraded by the 26s proteosome (Herschko and
Ciechanover, 1998; Gross-Mesllaty et al.,1998). This short half-life enables rapid down-
regulation of the protein and tight regulation of its activity (Gregory and Hann, 2000). Myc
function is dependent on binding to the b-}ìL}J-LZ domain of the Max protein (Amati er
al.,1993 and 1992) which allows binding to the promoters of target genes and modulation
of transcription. Another family of b-HLH-LZ proteins, the Mads, can also associate with
Max to elicit transcriptional repression of Myc target genes via binding to the E-box. The
onset of differentiation, and associated cell cycle withdrawal, is typically characterised by
the up-regulation of Mad family members, including Mad1, Mxil (Mad2), Mad3 and




A diagramatic representation c-Myc protein which shows:
o the domains of the protein, including the Myc box I (MBD and Myc Box 2
(MBII), the nuclear localisation sequence (NLS) and the basic helix loop helix
leucine (bHLHLZ) domain.
o that the bHLHLZ damair' is where Myc associates with Max
o the translational start sites of the c-Mycl, c-Myc2 and c-MycS subty'pes,
o the Threonine 58 and Serine 62 residues, which are phosphorylated as a
method of Myc protein stability control.
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7. 2. 1 Mvc/Max/Mad Assocíate d Trønscríptìonal C ontrol
Various studies have shown Myc activates and represses various genes involved with cell
cycle, cell growth, adhesion and apoptosis (Coller et al., 2000; Grandori and Eisenman,
1991; Jansen-Durr et al., 1993; O'Connell et al., 2003). Activation of Myc-mediated
transcription is dependent on Max association and also the N-terminal transactivation
domain. Full length c-Myc has been shown to activate in vivo reporter constructs linked to
fuIl-length promoters from putative target genes and synthetic, E-box containing promoters
(reviewed in Grandori et al., 2000). It has previously been demonstrated that the
transactivation domain (amino acid l-143) contains two 'Myc boxes', of which only MBI
(aa 44-63) is absolutely required for transcriptional activation, whilst MBII (aa 129-143)
has no transcriptional activity (Kato et a1.,1990; Atchley and Fitch, 1995). The function of
MBII in gene transcription has been shown to be involved with its association with TRAPP
(Transformatiorltganscription domain associated protein) (Brough et al., 1995; McMahon
et a\.,1998), which has roles in recruiting the histone acetyl transferase enzpq hGCN5
and Tip60. Acetylation of histones at target promoters results in an open chromatin
conformation and promotes transcription by allowing progression of transcriptional
machinery along the DNA (McMahon et aL,2000; Frank et aL.,2003). High levels of Myc-
associated deacetylation has been directly shown at the TERT (Xu et aL.,2001) and Cyclin
D2 promoters (Bouchard et a1.,2001). Conversely, only a modest up-regulation of histone
acetylation is observed at Myc-associated cad and odc promoters when there is a strong
up-regulation of transcription associated with re-entry to the cell cycle (Eberhardy et al.,
2000). At these promoters the Myc/Max complex recruits a P-TEFb, a kinase that
phosphorylates RNA polymerase II as a method of promoting transcription (Eberhardy and
Farnham,2001).
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The role of Myc as a transcriptional activator is opposed by the action of the Mad proteins
(Ayer et al.,1993). The N-terminus of the Mad proteins contains a region essential for the
repressive role of Mad, termed the Sin3 Interaction Region (SIR) which binds Sin3 (Ayer
et al. 7995, Kasten et aL.,1996; reviewed inZhou and Hurlin, 2001). Sin3 associates with
histone deacetylases (HDAC), which enhance gene silencing via deacetylation of histone
tails and closed chromatin conformation (reviewed in Ahringer, 2000).
Recent characterisation of Myc transcriptional regulation has revealed that whilst Myc has
roles as a transcriptional activator it also has many roles as a transcriptional repressor. Miz-
1 is a transcription factor that activates transcription of the cyclin dependent kinase
inhibitors, p15^*0" and p2l"iot. The association of Myc/Max dimers to Miz-l at the
initiator (Inr) regions of the pl5t**'u and p21"iP1 genes prevents transcription byblocking
interaction of Miz-l to its co-activator, p300 (Staller et al., 2001; Wu et al., 2003). This
method of transcriptional repression is dependant on MBII and is shared by other Inr
binding transcription factors (Li et al., 7994), such as TFII-I (Roy e/ al., 7993). This
evidence, coupled with the results from Kato et al., 1990, suggests that MBI is involved
with transcriptional activation while MBII is involved with gene repression. Consequently,
it has been shown that Myc is involved in the repression of a wide variety of genes,
predominantly involved with activation of differentiation and cell cycle arrest (Amundson
et aL.,1998; Coller et a1.,20001'Lee et a1.,1997; Claassen and Hann,2000; Philipp et al.,
1994).
1.2.2 Activøtìon of Mvc
Myc is widely considered a general downstream effector of proliferation signals as
mitogen stimulation causes increases in its transcription, translation and protein stability
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(Spencer and Groudine, 1991). Platelet Derived Growth Factor (PDGF), Colony
Simulating Factor (CSF), Epidermal Growth Factor, Interleukin (IL) -7, IL-2 and other
mitogens, have all been shown to up-regulate myc transcnption and translation (See
Spencer and Groudine, 1991 for a review). Myc protein stability is also increased in
response to mitogenic stimulation. This is mediated via the activation of Ras, which is a
small GTP-binding protein critical to cell growth control and response to mitogenic
stimuli. Downstream of Ras activation is a signalling cascade involving MAPK (ERK) and
Raf, which conveys mitogen-activated cell cycle progression signals from the cell
membrane to the nucleus (Sears et a1.,1999).It has been shown in primary mouse embryo
fibroblasts that over-expression of both Ras and Myc is sufficient to cause transformation
(Land et al., 1983). Ras is also involved in the inhibition of ubiquitin-mediated Myc
degradation via the regulation of N-terminal phosphorylations in the MBI region of Myc at
Threonine (Thr) 58 and Serine (Ser) 62. Phosphorylation of Ser 62 stabilises the protein,
enhancing its half-life, while phosphorylation of Thr 58, which is dependent on Ser 62
phosphorylation, targets the protein for degradation via the ubiquitin/proteosome pathway.
Ras up-regulates Raf/MEK that results in ERK-mediated Ser 62 phosphorylation. Thr 58
phosphorylation is thought to be mediated via the constitutively expressed kinase, GSK-3,
which is inactivated by the Ras up-regulated PI-3K/AKT pathway (Sears et a1.,2000). This
process is summarised in figure I.2.lt has been shown that the half-life of Myc can be
increased from 30 minutes to over t hour via the mutation of Thr 58 (Sears et a1.,2000),
which has also been shown to be the most common point mutation in Myc found in
tumours (Huang et al., 1995). Mutation of Ser 62, however, results in a decrease in the
proteins half life to approximately 10 minutes (Sears et al.,2000).
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Figure 1.2
The role of Ras in the stabilisation of the c-Myc protein in response to growth











1.2.3 The Role of Mvc ìn Cell Cvcle Reeulation
1.2.3.1The Mammalian Cell Cycle
The mammalian cell cycle is a tightly regulated process, which allows the ordered
duplication of chromosomes and cell division. The cell cycle is divided into 4 discreet
phases, termed Gl, S, G2 and M-phase. Chromosomereplication occurs in S-phase and
cell division occurs in M-phase. These phases are separated by Gl and G2-phase, in which
the cell will sense its environment to assess whether it should enter the next phase
(reviewed in Donjerkovic and Scott, 2000). The ordered progression and rate of the cell
cycle is controlled via the ordered activation of a family of kinases, termed the cyclin
dependent kinases (cdk). Activation of the catalytic cdk subunit is dependant on
association with the regulatory Cyclin subunit, allowing phosphorylation of targets
involved in cell cycle progression. While the level of the cdk typically stays constant
throughout the cell cycle, Cyclin levels are restricted to discreet phases (reviewed in
Morgan, I99l). The cell cycle is summarised in figure 1.3.
Following mitosis, when the two daughter cells are separated, all cdk activity is destroyed.
It is not until mid-Gl that Cyclin D proteins are up-regulated, resulting in the association
with cdk4 and cdk6 and the phosphorylation of Gl-targets. One of the targets of the Gl-
phase cyclirVcdk complexes is the Retinoblastoma protein (Rb), which is a repressor of the
transcription factor, E2F (Helin et al., 1993). This cdk-dependent phosphorylation releases
the Rb protein from its complex with E2F allowing transcription of genes that control Gl-S
phase progression. One such gene transcribed by E2F is CyclinE. Active CyclinBlcdk2
complexes are able to phosphorylate targets involved with entry into S-phase, including Rb
(reviewed in Ekholm and Reed, 2000).
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Figure 1.3
Control of progression through the phases of the Mammalian Cell Cycle. These










Cdk activation is also regulated by two other methods, other than Cyclin association.
Activation is opposed by the action of cdk inhibitors such as p2l"ipt and p27kpl that
associate with cyclirVcdk complexes (reviewed in Sherr and Roberts, 1999).
Phosphorylation on specific Cdks can result in either activation or repression of
Cyclin/Cdkcomplexes(Poon eta1.,1994; Solomon etal.,l993;MitraandSchultz,1996).
1.2.3.2 Myc-mediated Cell Cycle Progression
One way Myc is thought to promote cell cycle progression is through induction of cyclin
gene transcription. In mouse fibroblasts under serum starved conditions, over-expression of
Myc has been shown to induce the transcription of the Cyclin E and I genes and
progression into S-phase (Jansen-Durr et al., 1993). Myc is also a direct transcriptional
activator of the Cyclin D2 (Bouchard et al., 1999) and Cull gene (O'Hagaî et aL.2000).
Up-regulation of Cyclin D2lcdk4 complexes results in the sequesteration of the cdk
inhibitor, p27, from Cyclin Elcdk2 complexes (Bouchard et aL., 1999) and Cull induces
p27 ubiquitination and degradation (O'Hagaî et al. 2000) resulting in increase in net
CyclinE/cdk2 activity. Myc also directly activates the Cdc25A gene, the protein product of
which, is involved in removing inhibitory phosphates from cdk2, inducing activation of the
Cyclin Elcdk2 complex (Sexl e/ al., 1999). Myc-mediated Cdc25A and Cyclin E up-
regulation is also thought to drive G1- to S-phase progression of the cell cycle in the
absence of E2F function (Santoni-Rugiu et a1.,2000) though a mechanism for this process
is yet to be defined. These events are summarised in figure 1.4.
Myc has also been shown to repress genes involved with inhibition of cell cycle
progression, As discussed previously, Myc represses the Mizl-mediated transcription of
cdk inhibitors pl5rNKa" lstaller et a1.,2001) and p2l"ipt (wu et al., 2003). Myc also
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Figure 1.4
c-Myc has various roles in promoting cell proliferation via Gl-S phase
progression. These are involved with direct and indirect transcriptional activation
and possibly other non-transciptional roles. Figure constructed using information
from Jansen-Durr et ø1., 1993, Bouchard et al., 1999, O'Hagan et al., 2000,




































represses the transcription of Growth Arrest and DNA Damage genes, gadd34, gadd45 and
gaddL53 (Amundson et aL.,1998; Marhin et al.,l99l), Growth Arrest gene, gasl (Lee et
aL.,1997) and cdk inhibitor, p21 (Claassen and Hann, 2000). MBII has also been shown to
directly associate and sequester p2l protein as a method of reciprocal regulation which
results in lower available levels of, both, p2I and Myc (Kituara et a1.,2000).
1.2.4 The Role of Mvc ín Diffuteuliølìon
It has long been known that cell cycle modification is a consequence/prerequisite for
differentiation (reveiwed in Gao and Zelenka, 1997). As Myc is involved with activating
the proliferation (see 1.2.3.2) Myc down-regulation is also a feature of differentiation,
especially in terminally differentiating cells, which exit the cell cycle completely (reviewed
in Zhou and Hurlin, 2001 and Henriksson and Luscher, 1996). It has been shown that in
various cell types that the onset of differentiation results in a switch from Myc/Max dimers
to Mad/Max dimers (Xu et al., 2001;' Lin et al., 20001' Queva et al., 1998). This switch
results in the down-regulation of cell cycle activators and loss of inactivation of cell cycle
repressors (Xu et al., 200I; Lin et al., 20001' Queva et al., 1998; Wt et al., 2003), and in
many cases is essential to differentiation (Lin et aL.,20001, Maclean-Hwter et al., 1994).
The down-regulation of Myc in differentiation is also thought to be involved with the
silencing of various genes, via the loss of Myc-associated histone deacetylation at specific
sites (Lee et al,, 2003), and the up-regulation of Mad-associated HDAC activation (Queva
et a1.,1998; Xt et a1.,2001).Interestingly, it has been shown that reintroduction of Myc
into quiecent differentiated cells can cause re-entry into the cell cycle (Jansen-Durr et al.,
1 ee3).
9
Another role Myc has in differentiation is its effects on cell adhesion and cell growth.
Recent studies have demonstrated that Myc regulates genes and proteins involved with
translation, such as ribosomal subunits, adhesion molecules and metabolic enzymes (Shiio
et aL.,2003;Frye et aL.,2003; Coller et aL.,2000; O'Connell et aL.,2003; Amundson et al.,
1998; Iritani and Eisenman, 1999). These results indicate that action of Myc is involved
with structural changes to the shape of the cell, its attachment to it's immediate
microenvironment and metabolic functional changes within the cell during differentiation.
1.2.5 Mvc Alternative Trønslqtion Variants
Understanding the regulation of Myc has recently become more complicated as several
translational variants of the protein have been characterised. These variants arise through
initiation of translation from alternative start sites. Variants include c-Mycl, which arises
from an upstream CUG, c-Myc2, which is the most common form of the protein, arising
from translation from the ATG, and the downstream ATG-initiated, c-MycS subtypes
(Spotts et al., 1997;Xrao et al., 1998 and see Figure 1.2). The c-MycS protein, which lacks
the N-terminal 100 amino acids, lacks the highly conserved MBI and has been detected in
human, murine and avian cells. Like its full-length counterparts, c-MycS proteins, are
nuclear-localised short-lived phosphoproteins, which have the ability to dimerise with
Max. These proteins, as expected, are incapable of inactivating Myc target genes, and have
been associated with inhibition of full-length Myc-mediated transcription (Spotts et al.,
teeT).
While c-MycS proteins appear unable to activate transcription, it has become increasingly
clear that the cellular outcome of their expression is not unlike that of full-length Myc.
These proteins retain the ability to repress gasl and gadd45 (Xiao et al., 1998) and
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increase cdk2 kinase activity (Hirst and Grandori, 2000). c-MycS is still able to initiate
both proliferation and apoptosis in immortalised rodent cells (Xiao et al., 1998) and has
been shown to be up-regulated, to levels comparable to full-length, in rapidly dividing cells
(Spotts et a1.,1997). c-MycS is also more rapidly degraded than fuIl length c-Myc (Spotts
et al.,1997) possibly because it does not contain the site of stabilising phosphorylation at
Ser 62 (Sears et a1.,2000).
1.2.6 Mvc ønd Embrvoníc Development
During embryonic development myc RNA is widely expressed. c-myc RNA expression in
the gastrulating embryo is readily detected throughout the entire conceptus (embryonic and
extra-embryonic regions). At 7.5 dpc c-myc expression was detected at high levels in the
extra-embryonic lineages whilst in the primitive ectoderm proliferative zorre, showed only
modest expression. N-myc was detected at moderate levels in the 6.5 dpc embryo and
becomes highly expressed in the primitive streak and the primitive ectoderm of the 7.5 dpc
embryo. N-myc expression decreased during mesoderm formation and differentiation into
the epithelioid cells of the head process, somites and the nascent heart (Downs et aL.,1989;
Queva et a1.,1998).
Mice carrying functional mutation of the a-myc allele have impaired development and die
by 10.5 dpc. Generally, the embryos are small and form most cell types but display heart
defects, fluid-filled pericardia and neural abnormalities caused by improper closure of the
neural tube. The death of the embryos is thought to occur due to malnutrition caused by
poor vascularisation of the yolk sac (Davis et al., 1993). N-Myc knockout mice develop
normally until approximately 10.5 dpc but die at approximately 11.5 dpc, possibly caused
by failure of the major organs to develop (Sawai et al., 1993). L-Myc is expressed in
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embryogenesis in areas of proliferation and differentiation however L-Myc knockout mice
are viable, with few developmental defects (Hatton et al., 1996). This suggests that other
Myc family members may play redundant roles in development. This compensation
hypothesis is supported by the work of Malynn et al.,2000, when they replaced the c-myc
gene with anN-myc gene and demonstrated that knock-in mice developed normally. This
suggests that all Myc proteins may play similar roles in development but are expressed in
different spatial patterns. In contrast to the myc knockout embryos, Max knockout mice
cannot develop past the blastocyst stage of development. These mice die in early post-
implantation and at this stage are 50 - l}Yo smaller than wild-t1pe and Max Í/-
heterozygous embryos. It was suggested that the embryos in early development utilised a
matemal store of Max protein as was demonstrated by the high levels of Max protein in the
unfertilised egg and the 0.5 dpc embryo (Shen-Li et ø1.,2000).
1.3 Embryonic Stem Cells
Embryonic Stem (ES) cells are derived from the ICM of the mouse pre-implantation
blastocyst. ES cells can be maintained indehnitely in culture in the presence of the
cytokine, leukemia inhibitory factor (LIF) (Nichols et al., 1990). ES cells retain
pluripotency, as demonstrated by their ability to contribute to all the embryonic cell
lineages, including the germ line, when re-injected into blastocysts (Robertson et al.,
1986). ES cells also express the pluripotent cell marker, Oct4 (Rosner et aL.,1990), and the
ICM cell marker, Àex1 (Rogefs et al., l99l). Cell division times in ES cells are very rapid
(-12 hours) in comparison to somatic cells, which demonstrate cell cycle times in excess
of 24 hours (Stead et al., 2002). Observations in our laboratory demonstrate that these
rapid cell cycle times are associated with constitutively active cyclin Elcdk2 and cyclin
Alcdk2, which are thought to drive the rapid cell cycles associated with this period of
development (Stead, personal communication). The cell cycle kinetics in ES cells is
I2
compared to a somatic cell cycle in figure 1.5. There are also no detectable levels of cyclin
dependent kinase inhibitors, p27 andp27 (Stead et a1.,2002)
Culture of ES cells in the conditioned medium, MedII, leads to the formation of Early
Primitive Ectoderm-like (EPL) cells (Rathjen et al., 1999). This differentiation event in
vitro mimics the formation of primitive ectoderm in vivo. Like primitive ectoderm, EPL
cells retain pluripotency, as measured by Oct4 expression and express the primitive
ectoderm marker, Fglfs. EPL cells also retain the potential to form the primary germ layers
of the embryo, in vitro (Rathjen et al., 1999, Lake et al., 2000). Culture of ES or EPL cells
as aggregates in suspension, termed embryoid bodies (EB), induces ordered differentiation
mimicking the in yiyo events. ES cell EBs form lineages of all three primary germ layers
(Doetschman et al., 1985; Rathjen et al., 1999; Lake et a1.,2000). EPL cell EBs form
>95yo mesoderm as determined by their expression of the nascent mesoderm marker
brachyury (Lake et al., 2000). It has been shown previously in our laboratory that as ES
cells undergo differentiation into mesoderm, both cyclin F,lcdk2 and cyclin Ncdk2 activity
decreases (Stead, personal communication).
1.3.1 ES Cell Differentíatíon ønd Mvc
The role of Myc in ES cell differentiation has been previously studied using a fusion
protein termed RLF/L-Myc, found in human small cell lung carcinoma (SCLC). This
protein is produced by a chromosomal translocation and fusion of the cellular gene rlf to
the L-myc gene creating a protein, which contains the fulI length L-Myc with a 79 amino
acid extension from the RLF protein. Interestingly, expression of the RLF/L-Myc in ES
cells delays the formation of beating muscle and nerves in ES cells grown to form EBs. In
I3
Figure 1.5
c-Myc has various roles in promoting cell proliferation via Gl-S phase
progression. These are involved with direct and indirect transcriptional activation
and possibly other non-transciptional roles. Figure constructed using information
from Jansen-Durr et al., 1993, Bouchard et al., 1999, O'Hagan et a1.,2000,




















cells expressing high levels of the fusion protein cell death occurs at approximately 6 days
(Maclean-Hunter et al., 1994).
1.4 Aims
c-Myc is a potent cell cycle activator with various roles in proliferation and differentiation.
Given that c-Myc is also essential to embryonic development it may be deduced that c-
Myc may have a role in the activation of the rapid cell cycle times seen in the pluripotent
cell layers in the embryo and ES cells. Thus it was of primary interest to analyse the
endogenous expression of Myc protein in ES cells and during their differentiation into
embryoid bodies. Investigation of c-Myc expression levels during embryoid body
differentiation would enable elucidation of what functions of c-Myc may be required in the
differentiation of the pluripotent cell types of the embryo. Generation of antibodies that
would allow discrimination between different translational variants of c-Myc would
increase the understanding of how c-Myc may control the dynamic processes seen during
embryogenesis.
The switch from Myc/Max to Mad/Myc dimers during terminal differentiation has been
shown in various cell lines, such as HL60s (Xu et a1.,2001) and B Lymphocytes (Lin e/
al., 2000). As over-expression of Myc has also been shown to be sufficient for promoting
quiescent cells to re-enter the cell cycle (Jansen-Durr et al., 1993) it was of interest to see
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pH 7.5, NaCl (8 e), KCI (0.2g), KH2POa (0.2g),
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4.5mM citric acid; 2.25mM sodium citrate; 3mM sodium
chl oride ; 6 5 Vo methanol; 4%o p ara- form al dehyde
100mM L-glutamine in MQ HzO, filter sterilised and stored
as 1Oml aliquots at-20oC
Trypsin l:250 (Difco) (1g), lOml versene solution (10x
concentrate) to l00ml with MQ H2O
100mM P-ME in sterile PBS. Fresh solution prepared
fortnightly
0.2% (wlv) gelatin in PBS. Sterilised by autoclaving (20 psi
for 25 minutes at 140'C)
0.4 e Trypan blue, 0.81 g NaCl, 0.06 g KzHPO+ in 100m1
MQ H2O, pH7.4 hlter sterilised
DMEM (Gibco, BRL), pH 7.4, containing high glucose,
supplemented with 10% FBS
ES DMEM (Gibco, BRL), containing high glucose,
supplemented with 10% FBS, 0.1mM B-mercaptoethanol (B-
ME), 10% KNOCKOUTTMSR (Gibco, BRL), lmM
glutamine and 1000 U/ml of mLIF
ES DMEM (Gibco, BRL), containing high glucose,
supplemented with 10% FBS, 0.lmM B-ME.
ES DMEM (Gibco, BRL), containing high glucose,




ME), lmM glutamine, l0% KNOCKOUTTMSR (Gibco,
BRL) and the desired U/ml of mLIF
Conditioned medium produced by growing HepG2 cells to
subconfluency. Medium was harvested and filter sterilised
(0.22 ltrrù and stored at 4"C for up to 14 days (Rathjen et al.,
teee).
2.2.6 Cell Lines
All cells were maintained in tissue culture incubators aI37oC in I0o/o COz.
D3 ES: Derived from the ICM of the pre-implantation 129 strain mouse embryo blastocyst
(Doetschman et al, 1985). Kindly donated by Dr Lindsay Williams, Ludwig
Institute, Melbourne.
CMES: D3 ES cells as described above over-expressing a fuIl-length human c-Myc oDNA
under the control of the EF-lcx promoter. Construct transfected hc-Myc::pEF-IRES-
puro6. A complete map of pEF-IRES-puro 6 is contained in Appendix 1.
c-MycER ES: D3 ES cells as described above over-expressing a fuIl-length human c-
MycER cDNA (as described by Littlewood et al., 1995) under the control of the
synthetic CAG promoter as described in. Construct transfected
pCAGIpuro::MycER. A complete map of pCAGIpuro is contained in appendix 2.
MvcT58ER ES: D3 ES cells as described above over-expressing a full-length human c-
MycT58ER oDNA under the control of the synthetic CAG promoter. MycER ES
cell line with Threonine 58 of c-Myc, Quikchange mutated to Alanine. Construct
transfected pCAGIpuro::MycT58ER. As described inCartwnghl et al.
HL60: Promyelocytic leukemia from the periferal blood of a 36 year old Caucasian female
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2.3. Tissue Culture Methods
2.3.1 Geløtinised Tissue Culture pløtes
All tissue culture plates used for ES and EPL cells were gelatinised with 0.2o/o (wlv)
gelatin in PBS. Plates were covered with gelatin solution and left for at least 30 minutes at
room temperature. The gelatin solution was removed and the plate washed in PBS
immediately before use.
2.3.2 of cell number
Cells were harvested to a single cell suspension as described in 2.3.5 and 2.3.6. A 20pl
aliquot of the single cell suspension was diluted in 20pl of trypan blue. Cell numbers were
counted under 200x phase contrast magnification using a haemocytometer. Trypan blue
stained dead cells were omitted from the cell count.
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2.3.3 Stable ES Cell Líne Vìa Electronoratìon
2.3,3.1 Electroporation and Selection
Cells were harvested to a single cell suspension as described in 2.3.5 and 2.3.6 and a viable
cell count was performed as described in 2.3.2. The cells were then resuspended to 3-5x107
cells in 900p1 of cold (4'C) lx PBS. 10pg of linearised DNA was then added to the
solution and the solution was transferred to a electroporation cuvette (Biorad). The cells
were subjected to 500pF/0.2kV in a Biorad Gene Pulser with a Biorad Capacitance
Extender. Then they were transferred to 10ml of complete ES medium, plated into 4
gelatinised 100mm dishes grown overnight as described in 2.3.5. The following day
lpg/ml puromycin was added to the medium to allow selection of stably expressing
colonies. The medium was aspirated and fresh medium was added everyday for
approximately one week when resistant colonies started to form.
2.3.3.2 Picking Colonies
When the resistant ES colonies were large enough to pick the medium was aspirated and
the plate was washed with PBS. Under an inverted microscope the colonies were dislodged
from the plate and pulled up with aP200 pipette set to 30p1. The colony was then placed in
50¡rl of trypsin, left for 2 minutes and the cells were dispersed by the P200 pipette. The
cells were then transferred to a gelatinised 24 well tray and grown overnight in ES
complete medium. The following day the cells were returned to selection medium
containing lpglml puromycin. The cells were then passaged as describedin2.3.5.
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2.3.4 Thawíns stored cell lines
2.3.4.1ES cells
A vial of cells was removed from liquid nitrogen and placed in a37oC water bath. As soon
as the cells were thawed they were diluted in 10ml of fresh culture medium and spun at
1200 rpm for 4 minutes. Approximately 5 x 10s-1x 106 cells were then resuspended in the
appropriate medium and placed in a gelatinised 100mm dish, at 37"C, lÙYo COz in a
humidified incubator. The followingday, medium was replaced with fresh medium.
2.3.4.2 Additional cells lines
A vial of cells was removed from liquid nitrogen and placed in a 3l"C water bath. As soon
as the cells were thawed they were diluted in 10m1of fresh culture medium and plated in a
75cm2 flask. Thawed cells were cultured at 31"C, 5o/o COz in a humidified incubator.
Medium was replaced with fresh medium the following day.
2.3.5 Møintenance of ES and EPL cell lines
Embryonic stem (ES) cells were cultured on tissue culture grade plastic (Falcon) pre
treated with 0.2Yo gelatin/PBS. Semi confluent ES cell plates were washed with PBS
before the addition of trypsin (lml) prewarmed to 37"C for 2 minutes. A single cell
suspension was obtained by manual pipetting and transferred into 4ml of ES complete
medium. Cells were spun at 1200 rpm for2 minutes, gentlyresuspended in 10ml of fresh
ES complete medium and reseeded at a density ranging from 5 x 10s to 1 x 106 cells per
100mm dish and maintained in a humidified incubator at 37oC, ljY" COz as described in
Smith, (1991). ES cells were passaged every 2-3 days and maintained for a maximum of
30 passages.
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EPL cells were induced and maintained by culturing 1 x 106 ES cells in a 100mm dish pre-
treated with0.2%o gelatin/PBS (w/v) containing 50% ES Incomplete medium,50o/o MEDII
medium. EPL cells were usually derived after 2 days of culture. EPL cells were passaged
every 2 days for a maximum of 3 passages at 1 x 106 cells/lO0mm dish using the same
method described for ES cells. All experiments performed with EPL cells in this thesis
used EPL cells formed after 2 days. This was judged morphologically (flattened cells,
single cell layer) and confirmed by northern analysis as described in2.9.
2.3.6 Growth of Cells for LIF Títrøtion Analvsis
2.3.6.1Cell Culture
ES cells to be analysed by were plated into gelatinised 24 well trays. 500 cells were plated
per well and were allowed to grow for 24 hours in complete medium in a humidified
incubator at 37"C, IÙYo COz. The following day the medium was aspirated and the wells
were washed twice with lx PBS to remove all traces of complete medium. LIF Titration
Medium was then added to each well at the desired concentration of mLIF and the cells
were allowed to grow for 6 days. In the case of the experiments with the MycER ES cell
lines, 4-hydroxytamoxifen was added to the LIF Titration Medium at 100nM and the
medium was changed every second day. The medium was also changed every second day
in the minus 4-hydroxytramoxifen control.
2.3.6.2 Alkaline Phosphatase Detection
Alkaline Phosphatase was detected utilising an 86-R Alkaline Phosphatase Detection kit
(Sigma). This was done by aspirating the medium and fixing the cells in Alkaline
Phosphatase Fixative for 5 minutes. The cells were then washed several times in HzO
preceding the addition of the developing solution. The developing solution is prepared via
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mixing 200¡11 of FRV-Alkaline with 200p1 of Sodium Nitrate. After 2 minutes 9ml of H2O
and Napthol were added. When desired level of staining occurred the cells were washed
several times in HzO and allowed to air dry.
2.3.7 Møinten of HL-60 cells
HL-60 cells were grown as described by Steinman et a1.,1998. HL-60 cells were cultured
in75cm2 flasks in RPMI media supplemented with 10% FBS. Cells were not grown past
8x106 cells/ml and split every 4-5 days. When splitting, 5ml of cells was transferred to a
new 75cm2 flask and 45ml of RPMI+IO% FBS was added. The cells were grown in a
humidified incubator at3loC with a l\Yo C}z concentration.
2.3.8 Preparatíon of Embrvoid Bodies (EB's\
ES cells cultured under standard conditions were removed from tissue culture plastic as
described previously (2.3.4). After forming a single cell suspension, ES cells were plated
into bacteriological dishes at a density of 1 x 106 cells per 10cm2 dish and cultured in ES
incomplete medium. ES cells do not contact the bacteriological dish and form suspended,
free floating aggregates known as embryoid bodies. EB's were cultured for 7 days during
which, fresh and media was replaced every 2 days.
2.3.9 Hørvestìns Cells und Emhrvoìd Bodies
All cells were removed from tissue culture plastic by treating cells with l-2ml trypsin/PBS
for 4 minutes. Following dissociation from the plastic, trypsin was inactivated with 5-8ml
of incomplete medium. Cells were centrifuged at 1200 rpm for 2 minutes and washed 3
times in PBS. After removal of the PBS cell pellets were stored at -80oC.
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Suspended embryoid bodies were transferred to 30ml tubes and allowed to settle. The
embryoid bodies were washed three times in PBS and allowed to settle before removing
the PBS and storing the pellets at -80oC.
2.4 Moleculür Biology
2.4.1 Radiochemícals





APS: Sigma Chemical Co.
Bis-Acrylamide: Geneworks
B-ME: Sigma Chemical Co.
Bradford Reagant: Biorad Laboratories
Bromophenol Blue: Biorad Laboratories
BSA: Sigma Chemical Co.
dATP : Boehringer Mannheim
dCTP: Boehringer Mannheim
dGTP: Boehringer Mannheim
dTTP : Boehringer Mannheim
DTT: Sigma Chemical Co.
EtBr: Sigma Chemical Co.
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EDTA: Sigma Chemical Co.
Ethanol: BDH
Formaldeh yde (37 %) : B DH
Formamide: BDH (deionised and stored at-20oC)
Glycerol:BDH
Glycine: BDH
Glutathione Agarose : S cientifix, Zymatnx
HCl: BDH
Isopropanol: BDH
Leupeptin: Sigma Chemical Co
Magnesium Chloride: Sigma Chemical Co.
Methanol: BDH
MOPS: Sigma Chemical Co.
NP-40: Sigma Chemical Co.
Potassium Chloride: Sigma Chemical Co.
Potassium Acetate: BDH
PMSF: Sigma Chemical Co.
Tween 20: Sigma Chemical Co.
Ponceau S: Sigma Chemical Co.
Potassium Acetate: BDH
Sodium Acetate: BDH
Sodium Azide: Sigma Chemical Co.
Sodium Hydroxido: BDH
Sodium Orthovanadate: Sigma Chemical Co.
SDS: Sigma Chemical Co.
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TEMED: Sigma Chemical Co
Tris: Sigma Chemical Co.
Tris-HCl: BDH
Triton-X-l00: Sigma Chemical Co
2.4.3 Enzvmes





lx SDS PAGE running buffer
10x MOPS
2 X SDS load buffer
l0 x DNA/RNA loading dye
6 x SDS Loading Buffer
50mM Hepes, pH 7.9,250mM KCl, 0.1mM EDTA,
0.1mM EGTA, 0.4mM NaF, 0.4mM NaVO+, l0o/o
glycerol, 0J% NP40, 0.5 nM PMSF, l¡tg/ml
leupeptin, lmM DTT
12.5mM Tris-HCl, 100mM Glycine, 0.05% SDS,
20o/oMethanol
250mM Glycine,25mM Tris, 0.1% SDS
200mM MOPS pH 7 .0, 50mM NHaAc, 10mM EDTA
100mM Tris pH 6.8,20o/o glycerol, 4% SDS, 200mM
DTT
1 5 % Ficoll 400, 0.25o/o BPB, 0.25o/o Xylene cyanol
360mM Tris pH 6.8, 600mM DTT, 12% SDS,
0.006% bromophenol blue (BPB), 60o/o glycerol















130mM NaCl, 10mM Na2HPOa, 30mM NaHzPO+,
0. 1% Triton-X-100, pH 7 .2
0.5% Ponceau S, lYo acetic acid in MQ HzO
5o/onon-fat skim milk powder in PBST
50% MeOH (vol/vol); 0.05 brilliant (coomassie) blue
R250; 70%o acetic acid;40o/oHz}
30% MeOH;10% Acetic acid:,60YoHz0











ECL Chemiluminescence kit: Pierce
Western stripping kit: Alpha Diagnostics
Alkaline Phosphatase - 86-R: Sigma Diagnostics
Quickspin columns for Radiolabelled DNA Purifications: Roche Diagnostics
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2,4.7 DNA Molecular weisht markers
1Kb plus ladder: Life Technologies
2.4.8 Protein Molecular Weísht Markers
Rainbow Markers : Amersham
Low Molecular V/eight (LMW) Standard Markers: Amersham
2.4.9 IDNA Frasments Used For Probe Svnthesís
Fef5 was kindly provided by Dr. G Martin. This plasmid consisted of a fragment encoding
the full length mouse Fgf5 oDNA, cloned into the SmaI site of pBluescript KS+
(Hebert et al., 1991).
Rexl was kindly donated by Dr Neil Clarke. This plasmid contained 848bp of Rexl oDNA
in the Ecok[ site.
Oct 4 oDNA in pBluescript was provided by Dr Hans Scholer. This clone contained a
462bp StuI cDNA fragment spanning positions 491 to 953 of the Oct4 oDNA
sequence.
Brachlrury was kindly provided by Dr Bernhard G. Herrmann. The plasmid contained a
1764 bp of Brachyury oDNA cloned into the EcoRl site of pBluescript KS+
(Herrmann,199I)
GAPDH þmGap) contains 300 bp of the GAPDH cDNA sequence in pBluescript KS+
(Rathjen et a1.,1990).
Cyclin E was kindly provided by Nick Dyson. The plasmid contains 1.8 kb EcoRl
fragment of cyclin E cDNA.
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2.4. 1 0 Primørv Antíbodies
c-Myc (rabbit polyclonal N262) - sc-764
human Cdk2 (rabbit polyclonal }l42) - sc-163
Santa Cruz Antibodies
Santa Cruz Antibodies
2. 4. 1 1 S econdørv Antíbodies
Donkeyanti-rabbitimmunoglobulin-HRP(NA934V) Amersham
2. 4. 1 2 Olieoneucleotides
AbMycF 5' -dGGAATTCTGCCCCTCAACGTTAG-3'
CAGl 5' -dTCGGCTTCTGGCGTGTGACC-3'








pEF-IRES-puro 6 Kindly donated by Dr Dan Peet. For details see
Appendix 1




pSRûÀ{SVTKNEO::c-Myc Kindly donated by Grant McArthur, Peter Macallum
Cancer Institute, Melbourne. Full-length human c-Myc
oDNA inserted in an EcoRI site.
2.5 Moleculur Methods
2.5.1 Prepøration of Whole Cell Extrøcts
Cells were harvested from the dish by routine methods (2.3.4) and following 2 washes in
PBS were pelleted by centrifugation at 1200 rpm for 4 minutes. Residual PBS was
removed and pellets stored at -80oC (2.3.S). Approximately 100¡rl of lysis buffer per 106
cells was added to cell pellets. Cell pellets were disrupted by manual pipetting, then
incubated on ice for I hour during which they were vortexed for 5 seconds every 10
minutes. Soluble whole cell extracts were separated from insoluble cell debris by
centrifugation at 14,000 rpm for 10 minutes and the supernatant collected. Protein
concentration was determined colorimetrically using Bradford reagant (2.7).
2.6 Protein Detection Methods
2.6.1 SDS PAGE Anølvsis
SDS Page was performed as described by Laemelli, 1970. The separating gel (8-I2%) was
prepared using:
40% stock Bis-acrylamide solution (29 :1)
375mM Tris pH8.8
0.1% SDS
0.2% APS stock solution
O.I% TEMED
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Acrylamide gel percentage was altered by modifying the volume of 40%o Bis-acrylamide in
the gel solution. Either 0.75 or 1.5mm minigels (10 x 7cm) or 1.5mm large gels (16 x
llcm),were poured using Biorad or Oxford apparatus respectively and allowed to
polymerise for approximately 30 minutes beneath an overlay of butanol. After
pol¡zmerisation, butanol was removed and the stacking gel applied.
A 4% stacking gel was prepared using the same constituents described for the running gel
with the appropriate balance of 40o/o acrylamide stock solution and 20% APS stock
solution. Tris pH 6.8 was also used in replacement of Tris pH 8.8. 10, 15 or 20 well combs
were inserted and the gel was left to polymerise for another 30 minutes. Gels were run in
lX SDS PAGE running buffer. Minigels were typically run at a constant voltage of 150 V
while large gels were typically run at a constant voltage of 60V until the bromophenol blue
dye reached the bottom of the gel.
2. 6.2 Coomassie Støínins
Protein gels were placed in Coomassie Stain on a rocker for at Ieast 2 hours at room
temperature. The Stain solution was poured off and Coomassie destain solution was added
to the container and it was left on the rocker. Screwed up facial tissues were placed in the
container also to absorb the brilliant blue. The facial tissues were replaced intermittently.
When the gel was satisfactorily destained, the gel was scanned into a digital file on a HP
Scanner.
2. 6, 3 Il/estern Blottine
Proteins were transferred from 1.5mm unstained acrylamide gels to a 0.45pm
nitrocellulose membranes in a Biorad semidry transfer machine at a constant amperage of
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200m4 and voltage limited at25Y in western transfer buffer. Membranes were blocked in
PBS with 0.1% Tween (PBST) + 5yo dry milk from2 hours (at RT) to overnight (at 4"C).
Membranes were incubated with the primary antibody (diltuted according to manufacturers
instructions in PBST + 5%o dry milk) overnight at 4oC. Membranes were then washed 4
times for 15 minutes in PBST by rocking, and incubated for t hour at RT with HRP-
conjugated secondary antibody diluted according to manufacturers instructions in 5% skim
milk in PBST. HRP activity was detected with an ECL detection kit (Pierce) and exposed
to x-ray film (AGFA). Film was developed using an X-ray developer machine (AGFA,
Curix 60). All incubations with antibodies were performed while rotating using the nutator
(Clay Adams). Westerns were stripped for reprobing using the 'Western Stripping Kit
(Alpha Diagno stics) according to manufacturers instructions.
2. 7 Pr otein Con centrøtion D eterm inøtio n (B rødfor d Ass ay)
Protein concentration was determined by a method adapted from Bradford (1976). Known
standards of BSA protein (0.1, 0.5, 1,2.5,5, 10, 25,50,100pg) were pipetted into cuvettes
and adjusted to 20pl with lysis buffer. The protein samples to be tested were also pipetted
into cuvettes and made up to 20p1. lml of Bradford reagant (diluted l:4 in MQ water) was
added and mixed. A zero reference was prepared with 20pl of sample buffer mixed with
lml of Bradford reagant. The absorbance was measured using a UV spectrophotometer at
595nm (Pharmacia LKB Ultrospec III). The absorbance was standardised by measuring the
absorbance of the no protein reference and setting this at zero, then the absorbance was
measured for the known BSA standards and a standard curve of absorbance at 595nm
versus the protein concentration was plotted. Finally, the absorbance of the protein samples
was measured and the total protein determined by finding the absorbance on the standard
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curve and determining the correlating protein amount. The protein concentration was
calculated by dividing the total protein by the number of microlitres assayed.
2. 8 Antibody Prep&rution
2. 8. 1 C r e øtio n o f G S T-tøg s e d P r o t e iu.Exp r e.r S i U g B a.ctuttsl Lttt s $
pGEX-6P-1::N100 and pGEX-6P-1::N262 DNAs were transformed into BL21 E. coli
cells. Ampicillin resistant colonies were grown up in Luria
Broth/Ampicillin(100pglml)ll% glucose and glycerol stocks were prepared via adding
150p1 of glycerol to 750¡rl of bacterial culture and stored at -80oC.
2.8,2 Test Peptide Inductìons
2ml of Luria Broth/Ampicillin(lOOpglml)ll% glucose was inoculated from the glycerol
stocks of the pGEX-6P-1::N100 and pGEX-6P-1::N262BL2l strains and grown overnight
at 37oC. lml of the ovemight culture was pipetted into 10ml of Luria
Broth/Ampicillin(100pg/-l) and grown to OD6se:1 at37oC.200pl of the culture was then
added to 200p1 of 2x SDS load buffer. Peptide expression was induced by the addition of
0.1mM IPTG to the bacterial culture. 200¡.rl samples were taken evory I hour for up to 3
hours and added to 200¡rl of 2x SDS load buffer to analyse the induction. The samples
were then boiled at 100oC for 5 minutes and then approximately 60pl of each sample was
added to a 1.5mm thick SDS Polyacrylamide minigel. This was run as of 2.6.1 and
Coomassie Stained as in 2.6.2.
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2.8.3 Purifìcatìon of GST-Tøesed Peptìdes
50ml of Luria Broth/Ampicillin(l00pglml)ll% glucose was inoculated from the glycerol
stocks of the pGEX-6P-1::N100 and pGEX-6P-1::N262BLzl strains and grown overnight
at 37"C. This was then poured into a 500m1 of Luria Broth/Ampicillin(100pg/ml) and
groìwn to OD66e:1 at 37oC.IPTG was added to 0.lmM and the culture was left shaking at
room temperature overnight. The cells were then centrifuged at 3000rpm for 15 minutes in
a Beckman Benchtop Centrifuge. The Medium was then poured off and the centrifuge
bottle was weighed. lOml of STE buffer, with 25mM glucose; 5mM dTT; 50mM
benzamadine, was added per gram of cells and they were resuspended by vortexing. The
cells were lysed via passing them through the French Press twice. A 1/10 volume of STE;
10% Triton X-100 was added to the solution to the fìnal volume of IYo and the solution
was left rocking at 4C for 30 minutes. The solution was then spun in a Sorvall RC-5B
Refrigerated Superspeed Centrifuge in an SS34 rotor at 10,000rpm for 15 minutes at 4oC.
1ml of Glutathione Agarose beads was added to every 30ml of the supernatant with lTo
Sodium Azide and the mix was left rocking ovemight at 4"C. The tubes were then spun at
500rpm to bring down the beads, the supematant was aspirated and the beads were
transferred to a BioRad econo-column. The beads were then washed with 10 times bed
volume STE with 5mM dTT; 50mM benzamadine and the peptide was eluted in five lml
aliquots of STE with 10mM reduced glutathione. The amount of peptide eluted, in each
sample, was assessed by running on a SDS Polyacrylamide minigel and comparing protein
levels to BSA standards via coomassie staining as in2.6.2.
2.8.4 Antibodv Generøtion
Antibodies were raised in lop-eared and New Zealand White Rabbits. The first
immunisation contained lml complete freunds adjuvant, 200¡tg of antigen and PBS to a
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final volume of 2m1. The mix was emulsified and 200p1was injected subcutaneously into 5
sites each in 2 rabbits. The second immunisation occurred 3 weeks later with lml
incomplete freunds adjuvant, 200¡tg of antigen and PBS to a final volume of 2mL The mix
was emulsified and injected as above and the rabbits were left for 2.5 weeks until the third
immunisation. The third and all subsequent immunisations were performed with a
emulsion of 200pg of antigen, 100pg of MDP and PBS to 2ml. Following the course of
injections and test bleeds the rabbits were bled out and the antibodies were purified.
2.8.5 Affi.nitv Purífi.catíon of Antíbodìes
A2cm2 piece of nitrocellulose membrane was soaked in2ml of STE containing 100-200pg
of the desired peptide and sealed in a plastic bag. This was left rocking at room
temperature for 2 hours for the peptide to attach to the membrane. The membrane was then
taken from the solution and washed gently for 5 minutes, 4 times, in PBST. The membrane
was then placed in a plastic bag and 3-4ml of serum was added to the bag and sealed. The
association of the antibodies was allowed to proceed overnight, rocking at 4"C. The
membrane was then washed as above. Elution of the bound antibodies was achieved via
placing the rolled-up membrane in a screw-cap microcentrifuge tube and adding 900p1 of
0.1M Glycine, pH 2.5 and rotating it slowly at room temperature for 30 minutes. Following
removal of the membrane from the tube 100p1 of lM Tris, pH 8 was added to neutralise
the solution. Sodium Azide was also added to 0.02o/o and 900p1 of the total solution was




Cells were harvested from the dish by trypsinisation. Cells were washed twice and the
pellet frozen at -80oC until required. Total RNA was extracted using the RNAzol kit (Tel-
test). Cells were resuspended in RNAzol for 5 minutes and then disrupted by manual
pipetting. The RNA is extracted by the addition of 100p1 of chloroform and centrifugation
at 12,000 rpm for 10 minutes. The top layer was removed and placed into a new tube and
subjected to precipitation with 2 volumes of isopropanol. Precipitated RNA was then
washed with 10o/o ethanol and then air dried at room temperature. RNA was dissolved in
autoclaved distilled water.
2.9.2 Northern Transfer
15pg of RNA was dissolved in 20mM MOPS buffer, 5mM sodium acetate, 30%
formamide, 70o/o formaldehyde and 7pl of gel loading buffer and resolved on a lo/o agarose
gel at a constant voltage of 70V. The agarose gel was prepared by dissolving 1.5g of
agarose into 108m1 of water, followed by the addition of 15ml of 10 x MOPS buffer and
2lml of formaldehyde before the gel was poured into the gel cast. Gels were
electrophoresed in lx MOPS buffer at a limiting voltage of 70V. Following gel
electrophoresis, the gel was washed twice in RNAse free water. RNA was transferred to
nitrocellulose (Amersham) overnight by capillary action. The nitrocellulose was then air
dried before RNA was crosslinked by UV light at 120,000 microjoules.
2.9.3 Rqdioøctivelv Løbelline DNA Probe
The P32-ATP labelled probe was made using megaprime kit (Amersham). Primer was
annealed to the DNA template by adding approximately 150ng of DNA template to 5pl of
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primer solution in a final volume of 26¡i with MQ water, followed by heating of the
reaction at 95oC for 5 minutes. The reaction was allowed to cool at room temperature





5 ¡rl Reaction buffer
5 pl ø-P32dAtr
The reaction was started following the addition of 2¡rl of Klenow and incubated at 37'C for
15 minutes. Radiolabelled DNA probe was purified from excess radioactive nucleotide by
centrifugation through Q-spin columns. The resultant probe was the denatured by heating
at 95oC for 2 minutes and then cooled on ice for 5 minutes.
2.9.4 Hvbrídisøtíon ønd washine
Membranes were prehybridised in Ultrahyb (Amersham) from 2 hours to overnight.
Radioactively labelled DNA probe was added to the hybridisation mixture at a
concentration of 10ng probe/ml of hybridisation buffer and incubated overnight.
Membranes were washed twice for 5 minutes in 2 x SSC, 0.1% SDS aI42oC, and twice for
15 minutes in 0.lx SSC at 42oC. Membranes \¡/ere exposed to Kodak Imaging Screen and
developed and quantitated using a Biorad Molecular Imager@ FX.
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2. 1 0 Bøcteriøl Munipulation Methods
2. 10.1 Calcìum Chloríde Plasmíd Transformøtion
45pl of E coli cells were thawed on ice. lng of DNA was added to the cells and the mix
was incubated on ice for 30 minutes, then placed in a 42oC water bath for 2 minutes and
then on ice for 2 minutes. lml of BHIB was then added to the cells and placed at 37"C for
30 minutes. The cells where then plated on L+AMP plates and incubated at 37"C
overnight.
2.70.2 Pløsmid Prepørøtíon from Bøcterìal Cells









C.MYC IN ES CELL
3.1 Endogenous c-Myc Expression in ES Cells ønd ESEBs
3.1.1 Introduction
The Myc family are essential regulators of early mouse embryogenesis as has been
demonstrated by expression and knockout studies. Both c-myc andN-myc RNA are widely
expressed during embryogenesis (Downs et a|.,1989) and the knockouts of c-myc (Davis
et al., 1993) andN-myc (Sawai et al., 1993) leads to early embryonic lethality, at l0.5dpc
and 11.5dpc, respectively. Max knockout mice die in early post-implantation, prior to
gastrulation, demonstrating that the disruption of the entire Max network, which includes
Myc function, is essential for the differentiation of the pluripotent cell lineages into the
three primary germ layers. These mice were also 50 -70% smaller than wild-type and Max
-l/- heterozygous embryos. It was also suggested that the embryos, in early development,
utilised a maternal store of Max protein as was demonstrated by the high levels of Max
protein in the unfertilised egg and the 0.5dpc embryo (Shen-Li et aL.,2000). Malynn et al.,
2000 demonstrated that functional compensation between the c- and N-Myc proteins can
occur during embryogenesis and this compensation may be attributed to the fact that c- and
N-myc knockouts survive as long as they do.
As Myc proteins appear to be essential for differentiation in the embryo they would be
expected to be involved with the differentiation of the ICIli4 in vitro equlalent, embryonic
stem cells. Both ES and EPL cells can be differentiated into embryoid bodies. While this
system lacks spatial organization, it is a trusted in vitro model for the differentiation of
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ICM cells into nascent mesoderm (Rathjen et aL.,1999;Lake et a|.,2000). Thus, Northern
and Western analysis was employed to elucidate the expression of c-Myc RNA and protein
as ES cells differentiate into ES Embryoid bodies (ESEBs). ESEBs were used instead of
EPLEBs as they differentiate into all three primary germ layers and
3.1.2 Analvsis of ESEB Differentìøtíon
To analyse the kinetics of ES cell differentiation, ES Embryoid Bodies (ESEBs) were
prepared as described in Section 2.3.7. The cells were harvested daily, the RNA was
prepared for Northern Analysis as described in section 2.9. The nylon membrane was
probed for various differentiation markers such as Rexl, Fgjfs, Oct4 and Brachyury to
verify differentiation kinetics as seen in Lake et a1.,1999. This result is shown in figure
3.1(a). GAPDH was utilised as a loading control as its expression is known to be constant
across the differentiation of ESEBs (Rathjen et al., 1999). Rexl, a marker of the ICM
(Rogers et al., l99l; Rathjen et al., 1999; Lake et al., 2000) is down-regulated as the
primitive ectoderm marker Fgf5 is up-regulated (Hebert, et al.,l99I; Rathjen et aL.,1999;
Lake et al., 2000). Down-regulation of Oct4 demonstrates that there is a loss of
pluripotency (Schöler et al., 1990; Schöler, l99l; Rathjen et al., 1999) and is associated
with up-regulation of Brachyur!, à marker for nascent mesoderm (Herrmann, 1991).
Ornithine decarboxylase (odc) is a known target gene of c-Myc (Bello-Femandez et al.,
1993) and its RNA expression is confined to day 1 of ESEB differentiation.
3.1.3 Expression of c-Mvc Protein Durins ESEB Dìfferentiation
To investigate the expression pattem of c-Myc protein during differentiation of ES cells
Westem Analysis was employed to detect c-Myc expression across the differentiation of
ES embryoid bodies. Embryoid bodies were formed by growing the ES cells in suspension
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in the absence of LIF (2.3.1). Every day cell samples were taken and protein was prepared
as described in 2.5.1. The anti-c-Myc (N262) antibody (2.4.10), that recognises the first
262 Nterminal amino acids of c-Myc (raised against human but detects both human and
mouse), was used to detect c-Myc. Cdkz protein levels were utilised as a loading control as
it has been demonstrated in our laboratory that its expression is constant during ESEB
differentiation (E. Stead, PhD Thesis).
Western analysis utilising this antibody to detect c-Myc was a relatively insensitive process
as the antibody detected c-Myc protein very weakly. Thus the results seen in this Chapter
are of very long exposures (greater than t hour) of the membrane to film. Across the
differentiation of ES cells into EBs, seen in figure 3.1(a), there were two prominent bands,
of different sizes, detected. One of these protein species migrated with a predicted
molecular weight of approximately 65kDa and another with a predicted molecular weight
of approximately 50kDa. The 65kDa band is detected in ES cells, its level decreases in day
1 and day 2 ESEBs and remains at this lower level until day 4. This suggests that fuIl-
length c-Myc was expressed at its highest level in ES cells and down-regulated following
differentiation. The 50kDa band appeared one day after withdrawal of LIF and expression
peaked on day 2 and continued to be detected at low levels for the rest of the time course.
This expression profile closely resembles the appearance of FgJfs, suggesting that as ES
cells differentiate into the in vitro equivalent of primitive ectoderm the 50kDa protein
species was up-regulated. This band is down-regulated before brachyury appears at day 4,
demonstrating that its expression is not associated with mesoderm.
The Westem result demonstrated that during the differentiation of ES cells into embryoid
bodies there may be a change in the translational control of the c-Myc protein. The upper
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Figure 3.1
(a) Northern analysis was utilised to assess the differentiation of ES embryoid
bodies and the expression of the c-Myc target gene, odc. Specific probes were
used to detect Rexl, Oct4, Fgfs and Brachyury Io assess the timing of
differentiation events. mGøp expression was used as a loading control as its levels
are constant across differentiation.
(b) 'Western analysis was utilised to analyse the expression of c-Myc protein
across the differentiation of ES embryoid bodies. The anti-c-Myc (N262) antibody
(2.4.10) was used to detect c-Myc and the anti-Cdk2 (M2) was used to detect
























band at approximately 65kDa is predicted to be the full-length c-Myc2, which is the ATG-
initiated, fulI length, c-Myc. There are a number of possible explanations for the
appearance of the lower band. This band may be a non-specific interaction. Alternatively,
it may be an intermediate breakdown product caused by increased degradation of Myc
during differentiation. This assumption is supported by the presence of the bands that are
detected in between the prominent bands. The 50kDa band could also be the 100aa N-
terminal truncated c-MycS protein, the translation of which is initiated at an ATG
downstream of the suboptimal c-Myc ATG and has been shown to run on Polyacrylamide
gels at approximately 50kDa (Spotts et a1.,1997).If this is true, the levels of c-MycS may
be higher than they are represented in this western as the N262 antibody is raised against
the first 262 N-terminal amino acids there may be only a sub-population of polyclonal
antibodies that detect epitopes in the 100-262aa region. This means that the real levels of
MycS protein may be understated in comparison to c-Myc2.
If the lower band is in fact c-MycS this suggests that there is possibly some type of Myc
translational regulation during differentiation, where changes in the Myc protein are made.
It appears from this analysis that full-length c-Myc expression is at its highest levels in
Rexl positive ES cells and is down-regulated rapidly as the cells differentiate into Fgf5
positive cells. Associated with this differentiation there is also an up-regulation of the
smaller protein species, closely related to when fg,f5 RNA is expressed at its highest
levels.
3.1.4 Conclusion
From this analysis it is evident that c-Myc protein levels are modulated during ES cell
differentiation. There clearly is a down-regulation of c-Myc2 protein as pluripotent, Oct4
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positive, cells differentiate into non-pluripotent lineages. Preceding this differentiation
there is an up-regulation of the 50kDa c-Myc band, possibly associated with a concurrent
up-regulation of Fgf5 expression. This indicates that high c-Myc expression appears to be
associated with rapidly dividing cells pluripotent cells and must be down-regulated in order
for the cells to differentiate into non-pluripotent cell lineages. As it is known that MycS
up-regulation is commonly associated with periods of rapid growth (Spotts et aL.,1997) it
may be deduced that c-MycS is associated with the rapid cell divisions of primitive
ectoderm cells, demonstrated by Snow (1971).
3.2 c-Myc Over-Expression During ES CeU Differentiøtion
3.2.1 Introduction
Down-regulation of c-Myc is widely considered to be a prerequisite for the transition of a
dividing cell to a non-dividing differentiated cell (Lin et a1.,2000;Xu et a/., 2001). This
may be attributed to the fact that as cells differentiate they remodel their cell cycle and
adopt the appropriate characteristics of the new cell type. It has been demonstrated in our
laboratory that as ES cells differentiate into EPL cells their cell cycles accelerate from
approximately 12.3 hours to approximately 8.1 hours. The differentiation of ES and EPL
cells as EBs is also associated with the remodelling of the cell cycle and a slowing of cell
cycle times (Stead, personal communication). This remodelling of the cell cycle is
characterised by the establishment of periodic expression of cell cycle regulators not
present in ES cells. Cdk2 and Cyclin E and A kinase activity becomes restricted to their
discreet cell cycle phases and Cdk inhibitors, p27 andp27, are up-regulated (E. Stead and
R. Faast, personal communication).
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From this information it may be infered that Myc down-regulation may be essential to
enable the transition from ES and EPL cells into the differentiated cell types in embryoid
bodies. This hypothesis has been tested in ES cells by Maclean-Hunter et aL.,1994 where
they demonstrated that the tumour-derived RLF/L-Myo is able to delay the differentiation
of ES cells as embryoid bodies.
3.2.2 Expression of Human c-Mvc in ES cells
To analyse the effect of over-expression of c-Myc on ES cells an expression vector was
constructed to enforce human c-Myc expression in ES cells. The 1395bp full-length human
c-Myc was excised from pSRcTMSVTKNEO::c-Myc (2.4.13) using EcoRI and cloned into
pEF-IRES-puro6 (2.4.13 and Appendix 1) containing an EF-1cr promoter, which allows
constitutive transcription in ES cells. This construct was linearised via a PvuI site in the
Ampicillin resistance portion of pEF-IRES-puro6, and transfected into ES cells, as
described in Section 2.3.3. pEF-IRES-puro6 alone was also transfected to create a negative
control cell line for experiments. Following the selection in lpg/ml puromycin individual
colonies were picked and expanded. These were subsequently separated with SDS-PAGE
and transferred to nitrocellulose. An anti-c-Myc (N2ó2) antibody (2.4.10) was used to
specifically detect the c-Myc protein by Western Analysis.
3.2.2.1 CMES c-Myc Protein Expression
Figure 3.2 demonstrates that of the puromycin resistant clones, clones l, 4, 5,6 and 8
express Myc at much higher levels than in the vector control and HL60 cells. Interestingly,
the Myc-expressing ES cell lines also appear to express the smaller protein sub-type
detected in the differentiation experiment described in 3.1. This may be the c-MycS
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Figure 3.2
Embryonic stern cells were transfected with the pEF-IRES-puro6::hc-Myc
construct and western analysis was performed on the several puromycin resistant
clones. c-Myc expression was detected by the anti-c-Myc (N262) antibody
(2.4.10) in clone number 1,4,5,6, 8 and 9. A cell line that was transfected with
the pEF-IRES-puro6 vector alone was included in the analysis as a negative
control. The anti-Cdk2 (M2) was used to detect Cdkz, the expression of which is
used as a loading control.
l
L






protein, as the downstream translation initiation sites are still present in the over-expressed
Myc.
3.2.2.2 CMES Morphology
The c-Myc over-expressing ES cells, termed CMES for g-lV[yc ES, appear morphologically
different to the untransfected ES cells and those expressing the vector alone. Severalx
colonies appear rounder and more dome-like (Figure 3.3). There are two potential reasons
why Myc may cause these morphological differences. The first is that Myc, to some extent,
prevents spontaneous differentiation, and this prevents the appearance of the flattened out,
differentiated colonies in the culture. The second possibility is that Myc is causing a down-
regulation genes and proteins involved with cell adhesion such as collagen, fibronectin,
intcgrins and actin (Coller et aL.,2000 Frye et a1.,2003; Shiio ¿/ a1.,2003). Consequently
the cells may have decreased attachment to the collagen matrix on the culture dish. This
would appear to mimic the effect that Myc reintroduction has on myc-null Ratl cells,
where attachment to the culture dish is greatly reduced (Shiio et al., 2003). This effect is
most apparent in hgure 3.3(a), where the two right most colonies are attached but appear to
be embryoid body-like.
3.2.3 The Effect of c-Mvc Over-Expression on ES Cell Dífferentíation
3.2.3.1ESEB Differentiation in the Presence of Puromycin
Initial investigation into the differentiation of ES cells over-expressing c-Myc was
performed by differentiating ES cells into ESEBs as described in 2.3.7. Two different
CMES lines, CMES-6 and -8 were selected and maintained in the presence of I¡tglml
puromycin for the period of the time course to ensure c-Myc expression. In this experiment
high levels of cell death were observed and thus, low amounts of cells were harvested.
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Figure 3.3
Morphology of ES cells which over-express human c-Myc. CMES lines 6 and 8
are shown in (a) and (b), respectively. The morphology of the vector alone cell





























































CMES lines 6 (c) and 8 (d) were differentiated into ES embryoid bodies in the
presence of puromycin and northern analysis was used to analyse any differences
in differentiation kinetics in comparision to vector alone ES cells (a) and
untransfected cells (d). Differentiation markers Brachyury, RexI and Oct4 wete
used to assess differentiation kinetics and the Ethidium Bromide stained agarose































Northern Analysis (2.9) was performed on the cells to allow detection of differentiation
markers and assess the effect of Myc over-expression on kinetics of differentiation (Figure
3.4). In this experiment ES and vector alone cells were differentiated as controls.
In this experiment, RexI expression decreased with the same kinetics in the CMES cell
lines 6 and 8 and the ES and vector alone controls. It was high in ES cells and down-
regulated in dayl ESEBs indicating the ES cells had differentiated at the normal rate. Oct4
expression in the CMES cell lines also decreased with similar kinetics to the parental ES
cells and vector alone cells. Interestingly Brachyury expression was not detected in either
of the Myc over-expressing cell lines indicating that nascent mesoderm was not being
formed in the Myc over-expressing cells even by day 5 in ESEB differentiation. Down-
regulation of Oct4 indicates a loss of pluripotency in the CMES cells nearing the end of the
time course indicating that there is possibly a transition into another non-pluripotent cell
type.
3.2.3.2 ESEB Differentiation in the Absence of Puromycin
As the addition of puromycin to the medium caused high levels of cell death in the CMES
cell lines during ESEB differentiation, these experiments were repeated in the absence of
puromycin. In these experiments there was negligible cell death in comparison to the
untransfected ES and vector alone cells. Western analysis (2.6.4) utilising the anti-c-Myc
(N262) antibody (2.4.I0) was employed to investigate the expression of Myc protein in the
CMES-6 and vector alone cell lines (Figure 3.5(a)). This indicated that Myc protein is
expressed at high levels in the CMES-6 cell line when compared to D3ES cells, but was
down-regulated at days 4,5 and 6 of differentiation. Down-regulation is, most likely, the
result of increased c-Myc ubiquitin-mediated degradation during ESEB differentiation as
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Figare 3.5
CMES-6 and vector alone ES cells were differentiated into ES embryoid bodies in
the absence of puromycin. Western analysis (a), utilising the anti-c-Myc (N262)
antibody (2.4.10), was used to analyse the expression of the c-Myc protein during
differentiation. Northern analysis (b), detected the expression of the
differentiation markers Brachyur!, F8f5, RexI and Oct4, the loading control































has been demonstrated by Cartwright et a1.,2003. It may also be due to the fact the EF-l cx
promoter is not maintained at a high level during ESEB differentiation (Cartwright,
unpublished data)
Interestingly, the 50kDa band, previously described in 3.1, appears to be differentially
expressed in Myc over-expressing cells, shown in figure 3.5, in a similar fashion to what
was seen for ES cells as shown in figure 3.1(b). A peak in expression of the 50kDa band
can be seen in day 2 CMESEB differentiation, reminiscent of when it is at its highest in ES
cells. Cdk2 protein levels are utilised as a loading control in this experiment.
Northern Analysis was utilised to analyse the behaviour of CMES-6 during differentiation
into ESEBs (figure 3.5(b). These cells differentiated in much the same way as the vector
alone cells, with the exception of Brachyury expression, which is up-regulated one day
later in CMES-6 EBs than ES cells expressing the vector alone. This indicates that nascent
mesoderm forms at day 4 in CMES cells and in day 3 in non-expressing cells in each case
correlating to the reduction of Myc protein levels (Figure 3.5(a)). As the ES cells
maintained in puromycin (3.2.3.1) were expected to retain c-Myc protein expression and
Brachyury was not detected when these cells differentiated, this suggests that the down-
regulation of Myc is important for the formation of mesoderm. Cyclin ¿ RNA was also
detected in this northern analysis and its levels were found to only be modestly up-
regulated in the c-Myc over-expressing ES cells. GAPDH was detected at relatively
constant levels in figure 3.5(b) demonstrating that the expression pattems seen in
differentiation markers is a true representation of their kinetics.
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3.2.3.3 EPLEB Differentiation
As over-expression of c-Myc appeared to delay ESEB differentiation it was of interest to
analyse the effect during EPLEB differentiation, where predominantly mesoderm is
formed (Lake et a1.,2000). To investigate this, CMES cell line 8 and untransfected ES
cells were differentiated in the absence of puromycin into EPL cells as describedin2.3.5
and both were grown as embryoid bodies as described in 2.3.8. Embryoid bodies were
harvested daily, as describedin2.3.9 and Northern Analysis was performed as described in
2.9.The levels of gene expression of Rexl, Oct4, Fgf5 and Brachyury were assessed to
analyse differentiation (figure 3.6). This figure demonstrates that whilst the CMES cells
lose ES cell-like characteristics, as assessed by RexI expression, albeit later than
untransfected cells, they appear not to lose pluripotency, as assessed by Oct4 expression,
for the 5 days EPLEB formation was analysed. This result is supported by the observation
that Brachyury, the nascent mesoderm marker, is barely detected in differentiating CMES
cells, indicating that these cells lose the ability to form mesodem, at high levels. This
result also indicates that there is a delay in the differentiation of CMES cells to lose ES cell
characteristics and become cells equivalent to primitive ectoderm, as Fgf5 expression
appears later in CMES cells when compared to untransfected cells. Interestingly, Fgf5 is
down-regulated when there is still a high level of Oct4 meaning that these cells retain
pluripotency but express, neither Rexl or Fglfs. This means the precise nature of the cell
type differentiated is difhcult to define.
Maintenance of ES cells in culture is dependent on the presence of the cytokine, LIF, in the
culture medium (Nichols et a|.,1990). The LIF titration assay is a tool to assess the level of
LIF required to maintain an undifferentiated, pluripotent, ES cells. This technique utilises a
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Figure 3.6
CMES-8 and vector alone ES cells were differentiated in to EPL embryoid bodies.
Northern analysis detected the expression of the differentiation markers Fgfs,
Rexl and Oct4. Loading was assessed via visualisation of the Ethidium Bromide
















staining procedure to detect activity of the Alkaline Phosphatase enzyme as a measure of
pluripotency (Hanel et al.,1990; Pease et a1.,1990).
3.2.4.1CMES Cells LIF Titrations
Typically ES cells in culture are maintained in 1000 units/ml of LIF to help prevent the
loss of pluripotency. However, Dr Gavin Chapman has shown, that this can be reduced to
40 units/ml without significant loss of ES cell characteristics (G. Chapman, PhD Thesis).
Thus, to assess the differences in the level of LIF requirement of c-Myc over-expressing
cells and non-over-expressing cells, CMES and vector alone, were gro'\Mn for 6 days in 40,
30,20,15, 10, 7.5, 5,2, 1,0.5 and 0 units/ml of ESGRO LIF, as described in 2.3.6.1. The
cells were plated out at 500 cells per well and grown for 6 days so the culture would not
reach confluency and the colonies would be big and easy to identify. Following this the
cells were stained for alkaline phosphatase activity as a marker of pluripotency (Hanel e/
al., 1990; Pease et al., 1990). This experiment was performed in quadruplicate and the
colonies in each well were counted and scored blind as:
* Colonies scored as round had no cells with a flattened diamond-shaped morphology.
x* Alkaline Phosphatase positive was scored as when more than 50Yo of the cells in the
colony were purple.
The number of each of the colony type was then averaged across the quadruplicates and
the standard error of the mean was calculated.
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Figure 3.7 shows the staining of the cells in decreasing LIF concentration and the results of
the counting and scoring of colonies. It can be seen from the graph in figure 3.7(b) that the
loss of ESlike colony formation in decreasing LIF concentration is reduced slightly by c-
Myc over-expression. The effect is moderate but repeatable and significant. The graph
demonstrates that ES cell-like colonies are rarely seen in the vector alone wells after 6 days
in 7.5 units/ml of LIF. Conversely, ES cell-like colonies are seen approximately at 20Yo
and 40Yo in CMES-6 and CMES-8, respectively, at 7.5 units/ml and ES cell-like colonies
approach 0o/o at 2 units/ml. Figure 3.7(c) demonstrates that the percentage of pluripotent
cells in low LIF concentrations (below 7.5 units/ml) is higher in c-Myc over-expressing
populations. This result, however, does not give strong evidence as to whether the
difference in maintenance of pluripotency between the vector alone and the c-Myc lines is
a result of overexpression of c-Myc or some by-product of clonal selection of colonies. As
only 2 cell lines were used it is unclear if the slightly significant result is a result of the
chance that vector alone is more dependent on LIF.
3.2.4.2 c-MycER LIF Titrations
As LIF titrations on the CMES cell lines showed only a slight decrease in the level of LIF
required to maintain ES colony characteristics it was expected that other c-Myc over-
expressing ES cell lines may show a similar effect. To test this a D3ES cell line over-
expressing c-MycER (2.2.6) was analysed by LIF titration. The c-MycER fusion acts as an
inducible c-Myc system. The ER-fusion, in the absence of ligand, binds heat shock
proteins, which result in the cytoplasmic localisation, and thus inactivation, of the protein.
The addition of the synthetic ligand, 4-hydroxytamoxifen (4-OHT), results in the
disassociation of the heat shock proteins, the exposure of the nuclear localisation sequence
of c-Myc and nuclear translocation, and thus c-Myc activation (Littlewood et al., 1995).
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Figure 3.7
LIF titration analysis was performed on CMES-6, CMES-8 and vector alone
cells. The cells were grown for 6 days in 40, 30,20, 15, 10, 7 .5, 5,2, l, 0.5 and 0
units/ml of LIF and then were stained for alkaline phosphatase activity. A photo
of the stained colonies is shown in (a). The colonies were then counted and scored
AS
o rourìd, ES-like morphology and alkaline phosphatase positive,
o flattened out, non-ES-like morphology and alkaline phosphatase positive,
o or flattened out non-ES-like morphology and alkaline phosphatase
negative.
The results were represented graphically in (b) and (c). The graph in (b) represents
the colonies scored as ES-like, as described in the first dot-point above. The graph
in (c) represents the colonies scored as alkaline phosphatase positive and results
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The c-MycER in these cells is under the control of the pCAG promoter, which has been
shown to not be shut down during ESEB differentiation (Niwa et a1.,1998).
LIF titration analysis was undertaken on MycER ES cells in quadruplicates of cells in the
presence and absence of 100nM 4-OHT, as describedin2.3.6. The colonies were scored as
described above (3.2.4.1), the standard error of the mean was calculated and all the results
were collated into the graph shown in Figure 3.8. The graph demonstrates that whilst cells
in both the presence and absence of 4-OHT lose ES morphological colony characteristics,
alkaline phosphatase expression is maintained for the 6 days of the experiment in the
absence of LIF and the presence of 4-OHT. This suggests that c-Myc must be down-
regulated in order for the cells to lose pluripotency and differentiate. Interestingly, less
than 40%o of colonies demonstrate ES cell-like morphology in both the absence and
presence of 4-OHT in 40 units/ml of LIF. It is unclear why these cells have an increased
dependence on LIF in the cells not maintained in 4-OHT.
3.2.4.3 c-MycT58ER Cells LIF Titrations
To confirm that c-Myc over-expression prevents loss of pluripotency, LIF titrations were
performed on another c-MycER cell line (2.2.6). The c-MycT58ER cell line over-expresses
a human c-MycER fusion with Threonine 58 mutated to Alanine. This c-Myc mutant does
not get targeted for ubiquitin-mediated degradation and thus is not down-regulated during
differentiation of ESEBs (Cartwright et al., 2003). LIF titrations \À/ere performed as
described above (3.2.4.1) and the results are shown in the graph in figure 3.9. This
demonstrated that in the absence of LIF and the presence of 4-OHT approximately 60%o of
colonies retain ES-like characteristics, as evaluated via a rounded colony formation and
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Figure 3.8
LIF titration analysis was performed on MycER cells in the presence and absence
of 4-OHT. The cells were grown for 6 days in 1000, 40, 30, 20, 75, 10,7 .5, 5, 2,
1, 0.5 and 0 units/ml of LIF and then were stained for alkaline phosphatase
activity. The colonies were then counted and scored as:
o rourd, ES-like morphology and alkaline phosphatase positive,
o flattened out, non-ESlike morphology and alkaline phosphatase positive,
o or flattened out non-ES-like morphology and alkaline phosphatase
negative.
The results were represented graphically. The bar graph represents the colonies
scored as ES-like, as described in the first dot-point above. The line graph
represents the colonies scored as alkaline phosphatase positive and results from
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LIF titration analysis was performed on MycT58ER cells in the presence and
absence of 4-OHT. The cells were grown for 6 days in 40,30,20,15,10,7.5,5,2,
l, 0.5 and 0 units/ml of LIF and then were stained for alkaline phosphatase
activity. The colonies were then counted and scored round, ESlike morphology
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alkaline phosphatase staining. Interestingly, in the absence of 4-OHT, alarge percentage of
the cells in 40 units/ml LIF did not form ES cell-like colonies
3.2.5 Conclusion
The c-Myc over-expression experiments discussed in this Chapter collectively suggest that
c-Myc may prevent the differentiation of pluripotent ES cells into other cell types. This is
because during both ESEB and EPLEB differentiation, constitutive c-Myc expression
maintains pluripotency and reduces levels of non-pluripotent cell formation. This indicates
that in order for pluripotent cells to differentiate, there must be a down-regulation of c-
Myc. This may be intrinsically linked to the role of Myc as a cell cycle regulator which
drives the rapid cell cycles in pluripotent cells but must be reduced in order for slower






PRODUCTION OF ANTI-c-MYC ANTIBODIES
4.1 Introduction
The modulation of c-Myc translation and the appearance of the smaller c-Myc protein
subtl.pes is a characteristic of various cell t1.pes (Spotts et al., 1997). The smaller MycS
protein has been characterised in various studies and has been shown to be able to promote
cell cycle progression and apoptosis in immortalised rodent cells (Xiao et al., 1998) and
up-regulated in rapidly dividing cells, such as NIH3T3, BHK and MEL cells (Spotts et al.,
teeT).
'l'he westem analysis of c-Myc shown in Chapter 3 demonstrated that during the
differentiation of ES cells into embryoid bodies, a 50kDa band was detected by the anti-c-
Myc (N262) antibody (2.4.10). The size of the band was an indicator that there may be an
up-regulation the c-MycS subtype during embryoid body differentiation. To elucidate if
this band seen in ES cell differentiation is in fact c-MycS an antibody was raised to
recognise the 100 most N-terminal amino acids of full-length human c-Myc. This antibody,
theoretically, would not detect MycS, which is identical to fulI length c-Myc except that it
lacks the 100 most N-terminal amino acids. Thus, if the 50kDa band is not detected by the
antibody, it would indicate that the band seen by the anti-c-Myc (N262) antibody (2.4.10)
is c-MycS.
Generation of this antibody would also provide a useful tool for other future experiments,
especially when used in combination with the N262 antibody. Its use in dual western
55
analysis would demonstrate where full length c-Myc and c-MycS are expressed, enabling
elucidation of the differential regulation of the translation of c-Myc protein.
4.2 Production of Human c-Myc Peptidefor Antibody Production
Expression of the N-terminal 100 amino acids (henceforth termed MycNl00) of human c-
Myc was performed via cloning the first 300bp of the human c-Myc oDNA sequence into
the pGEX-6P-1 (Amersham Pharmacia Biotech). The 300bp region was amplified via a
PCR reaction utilising the primers, cMyclOONAbR and AbMycF (2.4.12) and cloned via
an EcoRI site into the vector. c-MycNl00::pGEX-6P-1 was then transformed into BL2I E.
colibacteia and selected using ampicillin as described in 2.8.1. Test inductions of the GST
tagged MycN100 were performed as 2.8.2 and are shown in Figure 4.1. The predicted size
of peptide is 37-46kDa reflecting the molecular weight of GST which is 26.5kDa and the
predicted molecular weight of the N100 amino acids is between 11 and 20kDa. The reason
for the variation in size of this peptide is because full length c-Myc runs approximately
20kDa higher than c-MycS (Spotts et al., 1997) but the actual weight of the peptide is
11306.3Da fcalculated by the ExPASy Molecular Biology Server ProtParam Tool
(http://kr.expasy.org/cgi-bin/protparam)1. There is a strong band seen in figure al@)
migrating at approximately 40kDa however the induction in IPTG was not greatly
enhanced. To confirm that this band did indeed represent the MycN100 peptide, western
analysis was performed using an anti-c-Myc (N262) antibody (2.4.10). Figure 4.1(b)
demonstrates that the band seen in the inductions in figure a.I@) is in fact a Myc peptide.




Test induction of the o-MyoN1OO-GST peptide were performed on BL21 cells
transformed with the c-MycN100::pGEX-6P-1 plasmid. IPTG was added to the
LB and samples of the bacteria were taken every hour for three hours. The
samples were added to load buffer, boiled and were subjected to SDS-PAGE. The
gel was coomassie stained (a) to enable detection of the induced peptide. To
confirm that the band seen on the coomassie stained gel was c-MycN100-GST the
same samples were subjected to western analysis (b), utilising the anti-c-Myc





















The induction and purification of the GST tagged protein was performed as described in
2.8.3. lOpl of purified protein was run on a SDS PAGE and the purified peptide can be
seen migrating at about 40kDa. When compared to BSA standards, c-MycNl00GST is
estimated to be present in excess of 10pg in 10pl (>lpg/pl) as can be seen in figarc 4.2.
There are also 2lower bands seen on the gel. The upper species or band may be a truncated
form of the peptide and the lower band, based on its size, may be GST alone. 150p1 of
antigen was utilised for the injection into rabbits for polyclonal antibody production as
described in 2.8.4. Two rabbits, rabbit 54 and 55, were used to generate antibodies of
which, only serum from rabbit 54 appeared to detect c-Myc in ES cells. Data from rabbit
55 is not shown.
The positive control used when testing the antibodies was protein from a D3ES cell line
over-expressing full-length human c-MycER (constructed and provided by Dr Peter
Cartwright). Figure a3@) demonstrates that the whole crude serum used at a 112000
dilution in 5o/o skim milk detected a band just below the 105kDa marker via Western
Analysis (2.6.4).It has shown that the MycER is detected at approximately 100kDa by the
anti-c-Myc (N262) antibody (2.4.10) (Cartwright et aL.,2003).Interestingly, in both the ES
and MycER ES cells a band could be seen at approximately 70kDa, which is where mouse
c-Myc migrates on SDS PAGE. Afhnity purification of the serum against the c-
MycNlOOGST peptide was then performed as described in 2.8.5 and the purified
antibodies were used to detect c-Myc in the same protein samples used in a3@). The blot
shown in a.3@) demonstrates that at a 1/1000 dilution the Nl00 antibody detects a band in
the c-MycER D3ES cells just below the 105kDa marker, which is predicted to be the over-
expressed c-MycER protein. In both samples a band at approximately 70kDa is detected,
which is probably the fulI length mouse c-Myc. Comparison of 4.3(a) and (b) demonstrates
57
Figure 4.2
Affrnity purification of c-MycNlOO-GST was performed and the five lml samples
eluted by reduced glutathione were subjected to SDS-PAGE and coomassie
stained (a). BSA standards (4 and S pg) were also run on a gel and coomassie
stained (b) to allow approximate estimation of the amount of c-MycNl0O-GST



















Following inoculation of Rabbit 54 with the c-MycNlOO-GST peptide serum was
harvested and this was used to perform western analysis at a dilution of 1/2000 on
ES and MycER whole cell extracts (a). Affinity purification of the serum to c-
MycN1OO-GST was then performed and this was used to perform western
analysis at a dilution of 1/1000 on ES and MycER whole cell extracts (b). Affinity
purified antibodies were then used to detect c-Myc expression during ESEB
differentiation (c). MycER extracts were utilised as a positive control and











































a significant reduction in the background and the strong band seen at approximately
105kDa is greatly reduced following affinity purification. As expected, in both of the
experiments no bands are detected at approximately 50kDa, where c-MycS would be
expected to migrate.
4.3 Analysis of Full-Length c-Myc Protein Expression During ESEB
Differentiation
As the affinity-purihed antibody generated from rabbit 54 (henceforth termed Ab54) was
able to detect mouse and human c-Myc in ES cells it was of interest to analyse the kinetics
of full-length c-Myc during ESEB differentiation. As was demonstrated in Chapter 3, the
50kDa band was absent in ES cells but was detected in day I and 2 ESEBs, thus it was of
interest to see if this band would be detected using the Ab54 in these days. Confirmation
that this band was not detected in these cells would give validity to the argument that this
band is c-MycS.
ES Embryoid bodies were prepared as described in 2.3.7 and cells were harvested daily for
whole cell protein extracts as described in 2.5). Western blot, utilising 4b54, was
performed to detect c-Myc across ESEB differentiation. MycER D3ES cells were used as a
positive control for this experiment and the result is shown in figure 4.3(c). This
experiment demonstrated that whilst a clear band is seen at approximately 70kDa, which I
have previously designated as full-length c-Myc2, there is no 50kDa band detected at any
stage of ESEB differentiation. The expression of the 70kDa band is consistent with the
western analysis, utilising anti-c-Myc (N262) antibody (2.4.10), shown in Figure 3.1.3.
This experiment was repeated with the same samples used in figure a3@) but
unfortunately the batch of the anti-c-Myc (N262) antibody (2.4.10) from Santa Cruz did
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not detect c-Myc at endogenous expression levels in ES cells. This meant that the
expression of c-MycS (or full length c-Myc) in these samples was not detected by this
antibody. The expression of full length c-Myc was confirmed by the Ab54 antibody and it
was shown that the levels of the protein were gradually down-regulated as differentiation
proceeded and failed to be detected by day 7 ESEB. The most significant down-regulation
of the protein, however, appears to occur at day 3 ESEB. This is the day when brachyury is
typically up-regulated suggesting that c-Myc2 needs to be down-regulated at this stage of
differentiation. This expression profile is similar to that shown in section 3.3.I, but there
are some differences that would need to be addressed via comparison of the Ab54 with a
N262 western result, on the same samples.
4.4 Conclasion
Coupled with the results of the western analysis from Chapter 3, crealion of the 4b54, anti-
c-Myc antibody provided evidence that there is an up-regulation of c-MycS during the
differentiation of ESEBs. The results in this Chapter support the evidence in Chapter 3 for
the appearance of c-MycS during periods of rapid cell division. The up-regulation of c-
MycS demonstrated in Chapter 3 appears to be associated with the up-regulation of Fgf5.
Interestingly, it has been shown in our laboratory that EPL cells, which are Fgf5 positive,
have more rapid cell cycle times than ES cells (Stead et a1.,2002). This evidence indicates
that up-regulation of c-MycS is associated with the rapid proliferation of cells equivalent
of primitive ectoderm, which is also known to rapidly proliferate within the embryo







The Myc family of proteins are activators of proliferation, apoptosis and cell growth (Ryan
and Birnie, 1996). Members of this family are widely expressed during development of the
mouse embryo (Downs et al., 1989; Queva et al., 1998) and knockouts of Myc genes,
typically, undergo abnormal development and early embryonic leathality (Davis et al.,
1993; Sawai et al., 1993; Hatton et al., 1996). The in vitro model of the pluripotent cells of
the ICM, ES cells, are a useful tool for the investigation of molecular regulators of the
dynamic process of embryogenesis. Utilising this tool, it was the purpose of this
investigation to elucidate possible roles of c-Myc in regulating the changes in pluripotent
cells that underlie their differentiation.
5.2 Chønges in c-Myc Expression During ES Cell Differentiøtion
Embryonic stem cells undergo very rapid cell division (12.3 hours) in comparison to
somatic cells which have cell cycle times in excess of 24 hours. ES cell cycles are
characterised by high levels of, non-cell cycle regulated, Cyclin E-associated kinase
activity (Stead et aL.,2002). Upon signals to differentiate into non-pluripotent cell lineages,
ES cells down-regulate their Cyclin E-associated kinase activity and restore more somatic
cell-like cell cycle structure (Stead, personal communication). A possible up-stream
regulator of these rapid cell cycles in pluripotent cells is c-Myc, which has roles in the
activation of Cyclin E and normal embryogenesis. Thus it was of great interest to analyse
the kinetics of c-Myc protein expression during the differentiation of ES cells.
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Two different sized bands are detected by western analysis utilising the anti-c-Myc (N262)
antibody (2.4.10). The bands that migrated slower had a predicted molecular weight of
65kDa on denaturing SDS-PAGE. This band would be expected to be, full-lengfh, c-Myc2,
which is down-regulated as ESEB differentiation proceeds. Its expression closely follows
the expression of Rexl, indicating that c-Myc2 expression be associated with pluripotent
ICM cells. The second band detected migrated at the predicted molecular weight of 50kDa.
There are several different possible identities of this band. It may be the result of a non-
specific interaction with a protein that is differentially regulated across this stage of ES cell
differentiation. It may also be an intermediate breakdown product of fuIl-length c-Myc
resulting from proteolysis of the protein. The other possibility is that this band is the c-
MycS protein, which arises from a down-stream translational start site in c-Myc. The
shorter c-MycS proteins have been demonstrated to be up-regulated in various cell types at
periods when there is rapid cell division (Spotts et al, 1997). This band is detected at its
highest levels in days 2 and 3 of ESEB differentiation, which correlates with when Fg1f5 is
detected and before Brachyury is detected at day 4. This would be expected to be a period
of rapid cell division, as it has been shown in our laboratory that, Fgf5 positive, EPL cells
have cell cycle times of 8.1 hours, in comparison to the 72.3 hour cell cycle times of Rexl
positive ES cells (Stead et al., 2002). This suggests that c-Myc2 is high in ES cells and c-
MycS may be up-regulated in the more rapidly dividing cells. Previously, it has been
shown in embryoid bodies and the embryo that following gastrulation there is a
deceleration in the cell cycle. In the embryo, the cells of the primitive ectoderm cycle in 5-
7 hours and the mesoderm cells cycle in22.2 hours (Snow, 1917).In Embryoid bodies this
stage of differentiation is associated with a more tightly regulated, more somatic cell-like
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cell cycle (Stead, personal communication). Potentially regulation of c-Myc is an up-
stream effector ofthis process.
5.3 The Effect oÍ Humø,n c-Myc Over-Expression on ES Cell
Differentiution
5.3.1 Introduction
As it was proposed that the down-regulation of c-Myc is essential for the differentiation of
pluripotent cells into more differentiated cells it was of interest to analyse what effect over-
expression of c-Myc would have on the differentiation of these cells. Experiments by
Maclean-Hunter et al (1994) have previously demonstrated that over-expression of the
tumour produced RLF/L-Myo fusion protein in ES cells, results in the delay of
differentiation into embryoid bodies, suggesting that Myc family members must be down-
regulated to allow normal differentiation.
5. 3. 2 Embrvoid B odv Differentìøtion
Generation of EF-lcr promoter driven human c-Myc over-expressing ES cells, provided
some early evidence that Myc down-regulation is essential for the differentiation of
pluripotent cells. The one day delay in the appearance of brachyurl expression in the
absence of puromycin and inability of the cells under puromycin selection to form
mesoderm, indicated that the differentiation of ES cells requires a down-regulation in c-
Myc. It can be seen in figure 3.5 that the appearance of brachyury is associated with down-
regulation of the protein levels of c-Myc on day 4 of ESEB differentiation. Interestingly, in
the CMES EPLEB differentiation experiment there was a delay in the Rexl to Fgf5
transition. This indicates that not only does c-Myc over-expression delay loss of
pluripotency, as seen by Oct4 expression, but it also may delay the differentiation of ES
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cells to other pluripotent cell t1pes. The low level of brachyury expression seen in this
experiment may be attributed to a small subpopulation of cells, which are able to
differentiate normally.
Interestingly, the 50kDa band also appeared in the c-Myc over-expressing cells during
differentiation as ESEBs, as is seen in figure 3.5(a). This indicates that the band is a
truncated form of c-Myc. It does not, however, clarify whether or not it is c-MycS or a
breakdown product of c-Myc resulting from changes in the level of c-Myc degradation
during di fferentiation.
5.3.3 The Effect of Human c-Mvc Over-Exnression on ES Cell LIF Dependence
Maintenance of ES cell pluripotency is dependent on the cytokine, LIF (Nichols et al.,
1990). Thus if over-expression of c-Myc is expected to maintain pluripotency, it may be
expected that c-Myc over-expressing ES cells may lose the requirement for LIF and thus
LIF titration analysis was utilised to test this hypothesis. Initial experiments utilising
CMES cells showed only a moderate retention of ES-like characteristics in decreasing LIF
concentration, in comparison to vector alone cells. Also , greater bhan 90Yo of colonies after
6 days in the absence of LIF were no longer pluripotent. Whilst these experiments showed
unremarkable results both of the c-MycER ES cell lines showed a more striking result,
suggesting that the CMES lines may down-regulate their c-Myc expression during the
period of the experiment. This may be reminiscent of the down-regulation seen in the
ESEB experiment in the absence of puromycin. Whilst the c-MycER cells lose ES celllike
colony characteristics in the absence of LIF, the cells in the presence of 4-OHT retain
pluripotency, as assessed by Alkaline Phosphatase activity. This tends to indicate that these
cells are able to differentiate from ES cells but cannot become non-pluripotent, and thus
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are possibly trapped in an early primitive ectoderm-like state. Interestingly, experiments
utilising the MycT5SER over-expressing cells demonstrate that in the absence of LIF and
thepresence of 4-OHT for 6 days, approximately 60Yo of colonies were scored as ES cell
colony-like. This reduction in LIF dependence for the maintenance of ES cells may be
attributable to the increased stability of c-Myc containing the T58A mutation, which makes
it resistant to ubiquitin-mediated degradation.
5.4 Generøtion of Anti-c-Myc Antibodies
'Western 
analysis utilising the anti-c-Myc (N262) antibody Q.a.l}) saw the differential
expression of two bands distinct in size. I have previously suggested that the 65kDa band
was c-Myc2 and there was a possibility that the 50kDa band was c-MycS. The smaller c-
MycS protein is generated from translational initiation at down-stream translational start
site and lacks the highly conserved MBI in the transactivation domain of the protein
(Spotts et aL.,1997). This protein, however, has been demonstrated to be involved with the
repression of genes, such as gasl and gadd45 (Xiao et a1.,1998) and rapid proliferation of
various cell types (Spotts et a1.,1991).
To provide evidence that the smaller band detected by the anti-c-Myc (N262) antibody
(2.4.10) is c-MycS, polyclonal antibodies were generated that would detect c-Myc2 but not
c-MycS. The converse experiment is not possible, as c-Myc2 and c-MycS are identical
except that c-MycS lacks the N-terminal 100 amino acids. Following generation of the
Ab54 antibody it was shown that it could detect both over-expressed human c-Myc from
MycER cells and endogenous mouse c-Myc2 in ES cells. This antibody was then used in
westem analysis on ESEBs to see if the 50kDa band was detected at any stage of
differentiation. As the species was not detected it provides evidence that this species is the
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c-MycS protein. This strengthens the argument proposed in 5.2, that c-MycS, is involved
with the rapid proliferation of Fgf5 positive cells and that MBI is not required or
detrimental to this proliferation profile.
5.5 Final Summøry
The Myc family of proteins have various roles in the control of cell proliferation, cell
growth, adhesion and apoptosis (Ryan and Birnie, 1996). They are important regulators of
embryonic development (Downs et al., 1989; Queva et al., 1998; Davis et al., 1993; Sawai
et aL.,1993; Hatton et al., 1996) and potent activators of the cell cycle (Jansen-Durr et al.,
1993; Bouchard et a1.,1999; O'Hagan et al. 2000). As it is known that pluripotent cells of
the embryo, and their in vitro equivalents, undergo dynamic changes in their cell cycle, it
became the focus of this investigation to analyse possible roles of c-Myc in the regulation
of this process.
Investigation indicated that c-Myc protein was expressed in the rapidly dividing,
pluripotent ES cells and this expression was down-regulated as the cells differentiated into
non-pluripotent cells. These cells exhibited slower, more tightly regulated cell cycles. It
was also demonstrated that during differentiation c-Myc appeared to undergo differential
translational control, where the shorter c-MycS protein appeared when Fgf5 was high. This
indicated that c-MycS expression may be associated with periods of rapid cell division in
ES cell differentiation.
Over-expression studies demonstrated that for ES cells to differentiate there must be a
down-regulation of c-Myc protein. This was predominantly shown to be associated with
the loss of pluripotency, when cell cycle time changes were most significant. It was also
6s
demonstrated via the reduction of LIF dependence in c-Myc over-expressing cells and the
delay in the differentiation of embryoid bodies.
In conclusion, c-Myc appears to be an essential regulator in the differentiation of
pluripotent cells and is a possible candidate for the regulator of the rapid cell cycle times in





Amundson, S.4., Zhan, Q., Penn, L.Z.r tnd Fornace, A.J. Jr. Myc suppresses induction
of the growth arrest genes gadd34, gadd45, and gaddl53 by DNA-damaging agents.
(1 998) Oncogene. 17 (17)z 2149 -21 54.
Amati, 8., Brooks, M.W., L.ty, N., Littlewood, T.D., Evan, G.I., and Land, H.
Oncogenic activity of the c-Myc protein requires dimerization with Max. (1993)
Cell.72(2)z 233-245.
Amati, 8., Dalton, S., Brooks, M.\il., Littlewood, T.D., Evan, G.I., and Land, H.
Transcriptional activation by the human c-Myc oncoprotein in yeast requires
interaction with Max. (1992) Nature,359(6394): 423-426.
Ahringer, J. NuRD and SIN3 histone deacetylase complexes in development. (2000) TIG,
16(8):351-356
Atchley, W.R. and Fitch, W.M. Myc and Max: molecular evolution of a family of proto-
oncogene products and their dimerization partner. (1995) Proc. Natl. Acad. Sci.;
92(22):10217 -10221.
Ayer, D.8., Lawrence, Q.4., and Eisenman, R.N. Mad-Max Transcriptional Repression
Is Mediated by Ternary Complex Formation with Mammalian Homologs of the
Yeast Repressor Sin3. (1995) Cell,80z 767-776
Ayer, D.8., Kretzner, L., and Eisenman, R.N. Mad: a heterodimeric partner for Max that
anlagonizes Myc transcriptional activity. ( 1 993 ) C e ll. 7 2 (2) : 2l | -222.
Bello-Fernandez, C., Packham, G., and Cleveland, J.L. The ornithine decarboxylase
gene is a transcriptional target of c-Myc. (1993) Proc Natl Acad Sci U S l. 90(16):
7804-7808.
Berns, K., Hijmans, 8.M., and Bernards, R. Repression of the c-Myc responsive genes
in cycling cells causes Gr arrest through reduction of cyclin EICDI<2 kinase activity.
(1997) Oncogene, l5z 1347-1356
Bouchard, C., Thieke, K., Maier, ,4.., Saffrich, R., Hanley-Ilyde, J., Ansorge, W.,
Reed, S., Sicinski, P., Bartek, J., and Eilers, M. Direct induction of cyclin D2by
Myc contributes to cell cycle progression and sequestration of p27. (1999), EMBO J.,
18(19): s32I-s333
Bouchard, C., Dittrich, O., Kiermaier,4., Dohmann, K., Menkel,4., Eilers, M., and
Luscher, B. Regulation of cyclin D2 gene expression by the Myc/Max/Mad
network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin
D2 promoter. (2001) Genes Dev.15(16)z 2042-2047.
Bradford, M. A rapid and sensitive method for the quantification of microgram quantities
of protein utilising the principle of protein-dye binding. (1976) Analytical
Biochemistry, 72: 248-254
67
Brough, D.8., Ilofmann, T.J., Ellwood, K.8., Townley, R.4., and Cole, M.D. An
essential domain of the c-Myc protein interacts with a nuclear factor that is also
required for ElA-mediated transformation. (1995) Mol Cell Biol.l5Q)z 1536-1544.
Cartwright, P., Rivett, D., and Dalton, S. LlF-independent Self-renewal of mouse
Embryonic Stem Cells by activated c-Myc. (2003) In manuscript.
Coller, H.4., Grandori, C., Tamayo, P,, Colbert, T., Lander, E.S., Eisenman, R.N.,
and Golub, T.R. Expression analysis with oligoucleotide microarrays revels that
MYC regulates genes involved in growth, cell cycle, signaling and adhesion. (2000)
PNAS,97(7)z 3260-3265
Dang, C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. (1999)
Mol Cell Biol. 19(1): l-11
Davis, 4.C., 'Wims, M., Spotts, G.D., Hann, S.R., and Bradley, A. A null c-myc
mutation causes lethality before 10.5 days of gestation in homozygotes and reduced
fertility inheterozygous female mice. (1993) Genes Dev.,7: 671-682
Doetschman, T.C., Eistetter, H., Katz, M., Schmidt, W., and Kemler, R. The in vitro
development of blastocyst-derived embryonic stem cell lines: formation of visceral
yolk sac, blood islands and myocardium. (1985) J. Embryol. Exp. Morphol. ST:27-
45
Donjerkovic, D., and Scott, D.W. Regulation of the Gl phase of the mammalian cell
cycle. (2000) Cell Res.10(1): 1-16.
Downs, K.M., Martin, G.R., and Bishop, J.M. Contrasting patterns of myc andN-myc
expression during gastrulation of the mouse embryo. (1989) Genes Dev.3z 860-869
Eberhardy, S.R., D'Cunha, C.4., and Farnham, P.J. Direct examination of histone
acetylation on Myc target genes using chromatin immunoprecipitation. (2000) J Biol
Chem. 27 5(43): 3 3798-3 3 805.
Eberhardy, S.R., and Farnham, P.J. c-Myc mediates activation of the cad promoter via a
post-RNA polymerase II recruitment mechanism. (2001) J Biol Chem. 276(51):
48562-48571.
Ekholm, S.V., and Reed, S.I. Regulation of G1 cyclin-dependent kinases in the
mammalian cell cycle. (2000) Current Opinion in Cell Biology,12: 676-684
Frank, S.R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H.M.,
Livingston, D.M., and Amati, B. MYC recruits the TIP60 histone acetyltransferase
complex to chromatin. (2003) EMBO Rep. 4(6):575-580
Frye, M., GarneÍ, C., Li, 8.R., Arnold, I., and Watt, F.M. Evidence that Myc activation
depletes the epidermal stem cell compartment by modulating adhesive interactions
with the local microenvironment. (2003 ) D ev el opment 130 (12) : 21 93 -2808
Gao, C.Y., and Zelenka, P.S. Cyclins, cyclin-dependent kinases and differentiation
(1997) BioUssays l9(4)z 307-315
68
Gardner, R.L. Manipulations on the blastocyst. (1971) Advan. Biosci. 6z 279-296.
Gardner, R.L. Origin and differentiation of extraembryonic tissues in the mouse. (1983)
Int. Rev. Exp. Pathol.24z 63-133.
Ginsberg, M., Snow, M.H.L., and Mclaren, A. Primordial germ cells in the mouse
embryo during gastrulation. ( 1 990) D evelopment ll0 : 52I -528
Grandori, C., Cowley, S.M., James, L.P., and Eisenman, R.N. The Myc/Max/Mad
Network and the Transcriptional Control of Cell Behavior. (2000) Annu. Rev. Cell
Dev. Biol.16z 653-699
Grandori, C., and Eisenman, R.N. Myc target genes. (1997) Trends Biochem Sci.22(5)z
177-l8l
Gregory, M.4., and Hann, S.R. c-Myc Proteolysis by the Ubiquitin-Proteosome
Pathway: Stabilisation of c-Myc in Burkitt's Lymphoma Cells. (2000) MoL Cell.
Biol. 20(7): 2423-2435
Gross-Mesilaty, S., Reinstein, 8., Bercovich, 8., Tobias, K.8., Schwartz, 4.L.,
Kahana, C., and Ciechanover, A. Basal and human papillomavirus E6 oncoprotein-
induced degradation of Myc proteins by the ubiquitin pathway. (1998) Proc Natl
Acad Sci U S A.95(1a): 8058-8063.
Hahnel, 4.C., Rappolee, D.4., Millan, J.L., Manes, T., Ziomek, C.4., Theodosiou,
N.G., Werb, 2., Pedersen, R.4., and Schultz, G.A.. Two alkaline phosphatase
genes are expressed during early development in the mouse embryo. (1990)
Development. 110(2): 555-564.
Hatton, K.S., Mahon, K., Chin, L., Chiu, F., Lee, H., Peng, D., Morgenbesser, S.D.,
Horner, J., and DePinho, R.A. Expression and Activity of L-Myc in Normal Mouse
Development. (199 6) Mo l. C ell. B io l. 16(4): 17 94-1804
Helin, K., Harlow, 8., and Fattaey, A. Inhibition of E2F-1 transactivaiton by direct
binding of the retinoblastoma protein. (1993) MoL Cell Biol. 13(10): 6501-6508
Hérbert, J.M., Boyle, M., and Martin, G.R. mRNA localization studies suggest that
murine FGF-5 plays a role in gastrulation. (1991) Development,ll2: 407-415
Herrmann, B.G. Expression pattern of the Brachyury gene in whole-mount TWis/TWis
mutant embryos. ( I 99 I ) D ev e I opment, ll3 (3) : 9 I 3 -9 17 .
Hershko, A, and Ciechanover, A. The ubiquitin system. (1998) Annu Rev Biochem.67:
425-479.
Henrikssotr, M., and Luscher, B. Proteins of the Myc network: essential regulators of cell
growth and differentiation. (1996) Adv Cancer Res.68:109-182.
Hirst, S.K., and Grandori, C. Differential activity of conditional MYC and its variant
MYC-S in human mortal fibroblasts. (2000) Oncogene.19(45): 5189-5197
69
Hoang,4.T., Lutterbach,8., Lewis, 8.C., Yano, T., Chou, T.Y., Barrett, J.F., Raffeld,
M., Hann, S.R., and I)ang, C.V. A link between increased transforming activity of
l¡rmphoma-derived MYC mutant alleles, their defective regulation by p107, and
altered phosphorylation of the c-Myc transactivation domain. (1995) Mol Cell Biol.
1s(8): 4031-4042.
Hogan, 8., Beddington, R., Constantini, F., and Lacy, E. Manipulating the Mouse
Embryo: A Laboratory Manual Cold Spring Harbour Laboratory Press, Cold Spring
Harbour, NY. (1994)
Iritani,8.M., and Eisenman, R.N. c-Myc enhances protein synthesis and cell size during
B lyrnphocyte development. (1999) Proc. Natl. Acad. Sci. USA 96: 13180-13185
Jansen- Durr, P., Meichle, 4., Steiner, P., Pagano, M., Finke, K., Botz, J.,
\ilessbecher, J., Draetta, G., and Eilers, M. Differential modulation of cyclin gene
expressionby MYC. (1993) Proc. NatL Acad. Sci. USA.I,90:3685-3689
Kasten, M.M., Ayer, D.8., and Stillman, D.J. ,S1l/3-Dependent Transcriptional
Repression by Interaction with the Madl DNA-Binding Protein. (1996) Mol Cell
B io 1., 1 6(8) : 421 5 -4221
Kato, G.J., Barrett, J., Villa-Garcia, M., and Dang, C.V. An amino-terminal c-Myc
domain required for neoplastic transformation activates transcription. (1990) Mol
Cell Biol. 10(11): 5914-5920.
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Iguchi-Ariga, S.M., and Ariga, H.
Reciprocal ..regulation via protein-protein interaction between c-Myc and
p2lctpt/wattrsdrr in DNA replication and transcription. (2000) J Biot Chem. 275(14)z
10477-10483.
Lake, J.4., Rathjen, J., Remiszewski, J., and Rathjen, P.D. Reversible programming of
pluripotent cell differentiation. (2000) Journal of Cell Science,113:555-566
Laemmeli, U.K. Cleavage of structural proteins during the assembly of the head
bacterioph age T 4. (l 970) Nature, 27 7 z 680-685
Land, H., Parada, L.F., and Weinberg, R.A. Tumorigenic conversion of primary embryo
fibroblasts requires at least two cooperating oncogenes. (1983) Nature. 1983
304(5927): 596-602.
Lawson, K.4., Meneses, J.J., and Pedersen, R.A. Clonal analysis of epiblast fate during
germ layer formation in the mouse embryo. (1991) Development,ll3:891-911
Lee, S.C., Bottaro, 4., and Insel, R.A. Activation of terminal B cell differentiation by
inhibition of histone deacetylation. (2003) Molecular Immunology 39= 923-932
Lee, T.C., Li, L., Philipson, L., and ZiffrE.B. Myc represses transcription of the growth
arrest gene gasl . (1997) Proc Natl Acad Sci U S A.94(24)z 12886-12891.
Li, L.H., Nerlov, C., Prendergast, G., MacGregor, D., and Ziff, E.B. c-Myc represses
transcription in vivo by a novel mechanism dependent on the initiator element and
Myc box II. (1994) EMBO J.13(17): 4070-4079.
70
Lin, K.I., Lin, Y., and Calame, K. Repression of c-Myc is necessarybut not suffrcient for
terminal differentiation of B lymphocytes in vitro. (2000) Mol Cell Biol. 20(23)z
8684-8695.
Littlewood, T.D., Hancock, D.C., Daniellan, P.S., Parker, M.G., and Evans, GI. A
modified oestrogen receptor ligand-binding domain as an improved switch for the
regulation of heterologous proteins. (1995) Nucleic Acids Res.23: 1686-1690
Lutz,, \il., Leon, J., and Eilers, M. Contributions of Myc to tumorigenesis. (2002)
Biochim Biophys Acta. 1602(1): 61-71.
Maclean-Hunter, S., Makela, T.P., Grzeschiczek, 4.., Alitalo, K., and Moroy, T.
Expression of a RLF/L-MYC minigene inhibits differentiation of embryonic stem
cells and embroid body formation. (1994) Oncogene,9: 3509-3517
Malynn, 8.A., Moreno de Alboratr, I., O'IIagan, R.C., Bronson, R., Davidson, L.,
DePinho, R.4., and Alt, F.W. N-rnyc can functionally replace c-myc in murine
development, cellular growth and differentiation. (2000) Genes Dev.l4z 1390-1399
Marhin, W.W., Chen, S., Facchini, L.M., Fornace, A.J. Jr, and Penn, L.Z. I|u4yc
represses the growth arrest gene gadd45. (1997) Oncogene. 14(23)z 2825-2834
McMahon, S.8., Wood, M.4., and Cole, M.D. The essential cofactor TRRAP recruits the
histone acetyltransferase hGCN5 to c-Myc. (2000) Mol Cell Biol.20(2):556-562
McMahon, S.8., Van Buskirk, H.4., Dugan, K.4., Copeland, T.D., and Cole, M.D.
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and
E2F oncoproteins. (1998) Cell.94Q)z 363-314.
Mitra, J., Schultz, R.M. Regulation of the acquisition of meiotic competence in the
mouse: changes in the subcellular localization of cdc2, cyclin 81, cdc25C and weel,
and in the concentration of these proteins and their transcripts. (1996) J. Cell. Sci.
109(Pt 9):2407-2415.
Morgan, D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. (1997)
Annu. Rev. Cell. Dev. Biol.l3z 261-291.
Nichols, J., Evans, 8.P., and Smith, A.G. Establishment of germline competent
embryonic stem (ES) cells using differentiation inhibiting factor. (1990)
D ev elopment, ll0 : 13 41 - 13 48
Niwa, H., Burdor, T., Chambers, I., Smith, A. SelÊrenewal of pluripotent embryonic
stem cells is mediated via activation of STAT3. (1998) Genes Dev,12:2048-60
O'Connell, 8.C., Cheung, 4.F., Simkevich, C.P., Tam, W., Ren, X., Mateyak, M.K.
and Sedivy, J.M. A Large Scale Genetic Analysis of c-Myc-regulated Gene
Expression Patterns. (2003) J. Biol. Chem.278(14)z 12563-12573
O'Hagan, R.C., Ohh, M., David, G., Moreno de Alboran, I., Alt, F.W., Kaelin,
W.G.Jr., and DePinho, R.A. Myc-enhanced expression of Cull promotes ubiquitin-
dependent proteolysis and cell cycle progression. (2000) Genes Dev. l4z 2185-2191
7l
Pease, S., Braghetta, P., Gearing, D., Grail, D., and Williams, R.L. Isolation of
embryonic stem (ES) cells in media supplemented with recombinant leukemia
inhibitory factor (LIF). (1990) Dev Biol.l4t(2)z 344-352.
Philipp, 4., Schneider,,A.., Vasrik, I., Finke, K., Xiong, Y., Beach, D., Alitalo, K., and
Eilers, M. Repression of cyclin D1: a novel function of MYC. (1994) Mol Cell Biol.
1a(6): 4032-4043
Poelmann, R.E. Differential mitosis and degeneration patterns in relation to alterations in
the shape of the embryonic ectoderm of early post-implantation mouse embryos.
(1980) Journal of Embryology and Experimental Morphology,5Sz 33-51
Poon, R.Y., Yamashita, K., Ilowell, M., Ershler, M.4., Belyavsky,4., and Hunt, T.
Cell cycle regulation of the p34cdc2lp33cdk2-activating kinase p4OMOl5. (1994) J.
Cell. Sci. 107(Pt l0\z 27 89-27 99.
Queva, C., Hurlin, P.J., Foley, K.P., and Eisenman, R.N. Sequential expression of the
MAD family of transcriptional repressors during differentiation and development.
(1 998) Oncogene, 16(8): 961 -977
Rathjen, J., Lake, J., Bettess, M.D., Washington, J.M., Chapman, G., and Rathjen,
P.D. Formation of primitive ectoderm like cell population, EPL cells, from ES cells
in response to biologically derived factors. (1999) Journal of Cell Science, ll2: 601-
6t2
Riley, P.R., Gertsenstein, M., DawsoÍ, K., and Cross, J.C. Early exclusion of handl-
deficient cells from distinct regions of the left ventricular myocardium in chimeric
mouse embryos. (2000) D ev B io l. 227 (l): 1 56- 1 6 8.
Robertson, 8., Bradley, 4., Kuehn, M., and Evans, M. Germ-line transmission of genes
introduced into cultured pluripotential cells by retroviral vector. (1986) Nature. 3232
445-448
Rogers, M.8., Hosler, 8.4., Gudas, L.J. Specific expression of a retinoic acid-regulated,
zinc-finger gene, Rex-l, in preimplantation embryos, trophoblast and spermocytes.
(1 991) Development., ll3: 815-824
Rosner, M.H., Vigano, M.4., Ozato, K., Timmons, P.M., Poirier, F., Rigby, P.W., and
Staudt, L.M. A POU-domain transcription factor in early stem cells and germ cells
of the mammalian embryo. (1990) Nature.345(6277)z 686-692
Roy, 4.L., Carruthers, C., Gutjahr, T., and Roeder, R.G. Direct role for Myc in
transcription initiation mediated by interactions with TFII-I. (1993) Nature.
365(6444): 359-36t.
Ryan, K.M., and Birnie, G.D. Myc oncogenes: the enigmatic family. (1996) Biochem J.,
314:713-721
Santoni-Rugiu, 8., Falck, J., Mailand, N., Bartek, J., and Lukas, J. Involvement of
Myc Activity in a Gr/S-Promoting Mechanism Parallel to the Rb/E2F Pathway.
(2000) Mol. Cell. Biol. 20(10): 3497 -3509
72
Sawai, S., Shimono, 4., Wakamatsu, Y., Palmes, C., Hanaoka, K., and Kondoh, H.
Defects of embryonic organogenesis resulting from targeted disruption of the N-myc
gene in the mouse. (1993) Development,llT(4): 1445-1455
Schöler, H.R., Ruppert, S., Suzuki, N., Chowdhury, K., and Gruss, P. New type of
POU domain in germ line-specific protein Oct4. (1990) Nature,344,435-439
Schöler, H.R. Octamania: the POU factors in murine development. (1991) Trends Genet.
7,323-329
Sears, R., Nuckolls, F., Ilaura, 8., Taya, Y., Tamai, K., and Nevins, J.R. Multiple Ras-
dependent phosphorylation pathways regulate Myc protein stability. (2000) Genes
Dev.14(19)z 2507-2574
Sears, R., Leone, G., DeGregori, J., and Nevins, J.R. Ras enhances Myc protein
stability. (1 999) Mol Cell. 3(2): 169-179.
Sexl, V., Diehl, J.4., Sherr, C.J., Ashmun, R., Beach, D., and Rousel, M.F. A rate
limiting function of cdc25A for S phase entry inversely correlates with tyrosine
dephosphorylation of Cdk2. (1 999) Oncogene, 18: 573-582
Shen-Li, H., O'Hagan, R.C., Hou, H.Jr., Horner, J.W.[., Lee, H., and DePinho, R.A.
Essential role for Max in early embryonic growth and development. (2000) Genes
Dev.,14: 17-22
Sherr, C.J., and Roberts, J.M. CDK inhibitors: positive and negative regulator G1-phase
progression. (1999) Genes Dev.l3z 1501-1512
Shiio, Y., Donohoe, S., Eugene, C.Y., Goodlett, D.R., Aebersold, R, Eisenman, R.N.
Quantitative proteomic analysis of Myc oncoprotein function. (2003) EMBO 2l(19):
5088-5096
Smith, A.G. Mouse embryo stem cells: their identification, propogation and manipulation.
(1992) Stem. Cell. Biol. 3: 385-399.
Snow, M.H.L. Gastrulation in the mouse: Growth and regionalizalion of the epiblast.
(1977) Journal of Embryology and Experimental Morphology,42z 293-303
Solomon, M.J., Harper, J.W., and Shuttleworth, J. CAK, the p34cdc2 activatingkinase,
contains a protein identical or closely related to p40MO15. (1993) EMBO J. l2(8):
3r33-3142.
Spencer, C.4., and Groudine, M. Control of c-myc regulation in normal and neoplastic
cells. (1991) Adv Cancer,Res. 56: 1-48.
Spotts, G.D., Patel, S.V., Xiao, Q., and Hann S.R. Identification of Downstream-
Initiated c-Myc Proteins Which Are Dominant-Negative Inhibitors of
Transactivation by Full-Length c-Myc Proteins. (1997) Molecular and Cellular
Biology. 17 (3)z 1459 -1468
Staller, P., Peukert, K., Kiermaier,4., Seoane, J., Lukas, J., Karsunky, H., Moroy, T.,
Bartek, J., Massague, J., Ilanel, F., and Eilers, M. Repression of pl5INK4b
IJ
expression by Myc through association with Miz-l. (2001) Nat Cell Biol.3(4)z 392-
399.
Stead, 8., \ilhite, J., Faast, R., Conn, S., Goldstone, S., Rathjetr, J., Dhingra, U.,
Rathjen, P., Walker, D., and Dalton, S. Pluripotent cell division cycles are driven
by ectopic Cdk2, cyclin E/A and E2F activities. (2002) Oncogene,2l(54)z 8320-
8333.
Steinman, R.4., Huang, J., Yaroslavskiy, 8., Goff, J.P., Ball, 8.D., and Nguyen, A.
Regulation of p21(WAF1) Expression During Normal Myeloid Differentiation.
(1998) Blood, 91, 4531- 4542
Stone, J., de Lange, T., Ramsay, G., Jakobovits, 8., Bishop, J.M., Varmus, H., and
Lee, W. Definition of regions in human c-myc that are involved in transformation
and nuclearlocalizalion. (1987) Mol Cell Biol.7(5)z 1697-1709
Vennstrom, 8., Sheiness, I)., Zabielski, J., and Bishop, J.M. Isolation and
charactenzation of c-myc, a cellular homolog of the oncogene (v-myc) of avian
myelocytomatosis virus strain 29. (1982) J Virol. 42(3)z 773-719.
'Watson, 4.J., and Kidder, G.M. Immunofluorescence assessment of the timing of
appearance and cellular distribution of Na/K-ATPase during mouse embryogenesis.
(1988) Dev. Biol.126(1)z 80-90.
Winkles, J.A. Serum- and polypeptide growth factor-inducible gene expression ln mouse
fibroblasts. (1998) Prog. Nucleic Acid Res. Mol. Biol.58: 41-78
Xiao, Q., Claassen, G., Shi, J., Adachi, S., Sedivy, J., and Hann, S.R. Transactivation-
defective c-MycS retains the ability to regulate proliferation and apoptosis. (1998)
Genes Dev. 12(24): 3 803-3808.
Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber,4., Menkel,4.R., and
Henriksson, M. Switch from Myc/Max to Madl/Max binding and decrease in
histone acetylation at the telomerase reverse transcriptase promoter during
differentiation of HL60 cells. (2001) Proc Natl Acad Sci U S A.98(7): 3826-3831
'Wu, S., Cetinkaya, C., Munoz-Alonso, M.J., von der Lehr, N., Bahram, F., Beuger,
V., Eilers, M., Leon, J., and Larsson, L.G. Myc represses differentiation-induced
p21CIP1 expression via aMiz-l-dependent interaction with the p21 core promoter.
(2003) Oncogene 22(3)z 351-360
Zervos,4.S., Gyuris, J., and Brent, R. Mxil, a protein that specifically interacts with
Max to bind Myc-Max recognition sites. (1993) Cell.72(2)z 223-232.
Zhou, 2.Q., and llurlin, P.J. The interplay between Mad and Myc in proliferation and




































PfÕl!!l!{ nffi.'i tEF.t¡lES-f{ '{! 6
Plc¡mld ð¡rri l,t4 hb
CGnúruc¡üú Þïl 0ûn F$û{
Corr.!¡sctlcn Élto: Ð907.?g
CornEil{ll¡fEtlfteñ€ût¡ lþda Irqr} pfF,tnff-¡¡¡e ã ùf rtñrôltîÐ ô!þql ùÊs b $eS
illñh ,q¡cquctêåðovñ


























Pl¡rí#. Br$ûr FCAÛIP uto
Flrrmld drG* 7!gl¡ bg
Cå{Etrì¡otr¡ by¡ lltl C¡ìüÈrrt A Hotæ ñ$aftron
Gon¡truorlon drü¡ ASü igfz
crcrrËÍt.rR.úürDoarr rìê prl - l¡al h*Dan¡ ¡nd ht tdoll . llotl lnln¡rll
(rffi4 d FtA@ mrü hÉd b I pcß F*dd tonr pftrp*oþr Gú¡r,dkrg rrmrrha
]\ro ATG to û¡. Ffidl dts t' b t¡c bû1fiÂ. FCR hûodufld r gspttt dtt ar ür* ATe
rtd rrlrfüd A,um üo Ptü.
CclEr od
90ryorltttuwff
nClOlÞsro
?É*lt bp
ü¡txl"rtÉltlf
n@
76
